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QUILL OiN SCALPEL This section
provides a medium through which Canadian 
surgeons can declare themselves, briefly and in­
formally, on the day-to-day affairs of surgery.
THROMBOSIS ON PROSTHETIC 
SURFACES
In this issue of the Canadian Journal 
of Surgery (page 339), Foster, Smith 
and Dobell review the extremely im­
portant subject of the prevention of 
clotting on prosthetic surfaces. The 
problem is of importance not only for 
the further development of an artificial 
heart and replacements for small ves­
sels and heart valves, for lessons learn­
ed from a study of these surfaces may 
be applicable to the prevention of throm­
bosis on viable surfaces.
Salzman,1 in a recent symposium on 
“ Mechanical Surfaces and Moving 
Blood” , states that it was formerly as­
sumed that to be “ non-thrombogenic” 
a material must be passive toward 
Factor XI, the earliest step in the 
intrinsic clotting system. It is now cus­
tomary to view surface-induced throm­
bosis as chiefly, if not exclusively, a 
platelet problem—formation of a white 
platelet thrombus. However, the “ red 
thrombus” is the characteristic lesion 
in peripheral veins, in the lung, behind 
stenotic mitral valves, on the endocar­
dial surface of infarcted myocardium, 
and around the sewing ring of artificial 
heart valves where eddy currents and 
vortices permit the accumulation of 
activated procoagulant clotting factors. 
In the development of non-thrombo­
genic material one must consider both 
platelets and plasma coagulation; local 
fluid dynamics will dictate which pre­
dominates.
Everyone is familiar with the clas­
sical experiment of William Hewson8 
who isolated a segment of canine jug­
ular vein between clamps and observed
that the blood within the vessel re­
mained fluid. When poured out into a 
bowl, the blood promptly clotted. More 
important in the present connection 
was the overlooked observation o f Hew- 
son that the blood did not remain fluid 
indefinitely, even when exposed only 
to normal endothelium. Minute clots 
were visible within an hour and com­
plete coagulation occurred within sev­
eral hours. These changes suggest that 
an ideally passive surface will not be 
enough to prevent thrombosis on pros­
thetic surfaces.
It is now clear that a combined knowl­
edge of materials, geometry, blood flow 
and the condition o f blood constituents 
is needed if the thrombogenic proper­
ties of artificial organs are to be re­
duced. All man-made surfaces cause 
plasma to deposit a film of protein and 
to clot; most, if not all, will cause at 
least some platelets to adhere, even 
when clotting is prevented. Proteins 
adsorb to negatively charged (anionic) 
surfaces, to heparinized surfaces, to 
cationic surfaces and to non-polar sur­
faces. The proteins adsorb very rapidly, 
in seconds, and the adsorbed film is a 
preliminary step in platelet attachment, 
thrombus formation, damage to red 
blood cells, and possibly to leukocytes. 
One of the best thromboresistant sur­
faces currently available was developed 
by Vincent Gott. This colloidal graph­
ite-coated methyl methacrylate was 
thought to inhibit blood clotting be­
cause of the smoothness of the surface. 
However, the ability of graphite to bind 
heparin was discovered to be the essen­
tial feature. Furthermore, it was pos­
sible to bind a greater concentration o f 
heparin to the surface if the graphite
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was rinsed with a cationic surface-ac­
tive agent, benzalkonium chloride, be­
fore exposure to heparin. Unfortunately, 
this coating cannot be applied to a flex­
ible surface.
What appeared at first to be a small 
problem for an interested hematologist 
is now the consuming occupation of 
talented researchers in fluid mechanics, 
surface chemistry, rheology and many 
other disciplines. The problem of con­
trol of thrombosis on prosthetic sur­
faces is patently beyond the resolving 
capacity of any single discipline because 
it is inextricably linked to several kinds 
of phenomena, each requiring a differ­
ent competence to investigate.
L. D. MacLean
References
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H ISTORY OF SURGERY
JAMES BELL’S APPENDICITIS
D. ALTON MURPHY, M.D., F.R.C.SJC],* Montreal, Que.
“ When in doubt, operate.”  James Bell, 1894
Ja m e s  B e l l  (Fig. 1) was the second 
Surgeon-in-Chief of the newly built 
Royal Victoria Hospital in Montreal. At 
the time of his death Dr. Bell was said 
to be one of the most able surgeons in 
America. He was known and respected 
internationally. His scientific biblio­
graphy of more than 100 papers dealt 
with a wide variety of subjects. Ironi­
cally, however, two of these articles,1' 2 
which clearly defined a form of treat­
ment of appendicitis, were of no avail 
in altering the course of his terminal 
illness.
Dr. Bell, who graduated from McGill 
Medical School in 1877, was awarded 
the Holmes Gold Medal for his scholastic 
excellence. He was a surgical resident 
at the Montreal General Hospital from 
this time until 1881 when he was ap­
pointed as the first Medical Superin­
tendent of that hospital. This salaried 
position, which carried no admitting 
privileges, was devoted to forwarding 
the interests of the hospital and gen­
erally managing its business affairs. He 
remained as Medical Superintendent 
until 1885.
During this period William Osier, his 
teacher and one of his friends, influ­
enced him to broaden his interests. His 
name appears with Osier’s on the roster 
of members of the Montreal Veterinary 
Association at that time. He ultimately 
became President of the Montreal 
Veterinary Association in 1881, a post 
held by Dr. Osier several years previ­
ously.3
In the spring of 1885 Dr. Roddick, 
later to become Sir Thomas Roddick, 
was appointed Assistant Surgeon-Gen­
eral to the militia fighting in the North 
West Territories against Louis Riel’s 
forces.4 Dr. Bell who, up to this time, 
had also been surgeon to the 6th Bat-
*Room 1130, The Montreal Children’s Hos­
pital, Montreal 108, Que.
Fig. 1.—James Bell, M.D., taken around 1905.
talion, Fusiliers in Montreal joined Dr. 
Roddick as the First Assistant-Surgeon 
and was stationed in Swift Current, 
North West Territories. Near the end 
of the Rebellion,5 he ran his own mobile 
field hospital unit, posted north of Sas­
katchewan Crossing.
Either he had a good press agent or 
was well liked, since, during his absence 
at the Rebellion, the advertisement 
shown in Fig. 2 appeared in the Mont­
real Gazette, Saturday, May 16, 1885, 
when a consultant post became vacant 
at the Montreal General Hospital.
It is unknown whether this influenced 
the Governors or not, but Dr. Bell was 
successful, becoming a Consultant Sur­
geon at the Montreal General Hospital 
in the summer of 1885. He was invited, 
in 1894, to join four other surgeons on 
the medical staff of the newly built 
Royal Victoria Hospital (Drs. Craik, 
Roddick, Buller and Gardner).6 Follow-
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piMtltauunu.
DR. JAMES BELL,
Who Is now on Milve nervlre In tho N»rth- 
v»e.H',li» a cr. ml Idu to for the Surntoal vacancy 
likely to occur In the staff of the Montreal 
General Hospital on the 81*1 Instant, amt ho- 
ln« unable personally to look after his Interest* 
in tho approaching election, his friend* ear­
nestly hope that Inc Governors will Rive his 
application their favorable considers'lo:i It 
I * hoped that l)r. Bell's lonu experience 'n 
hospital work—having been resident In the 
hospital for sis years—together with his well- 
known aptltudo for Hurgeiy. auil his Uuterml- 
nation to devote himself exclusively to that 
branch of tho profession tnay be taken into 
aooount In considering his claims, and hta 
friends feel astured that his unavoidable ab- 
sanoe on duty at the front will not be allowed 
to Injure his prospoota of election. A  short 
roolar setting forth his qualification some- 
hat more In detail, will he Issued In a day or 
two, and distributed among the Governors.
Montreal, May ith, 1»8». 106
Fig. 2.—Advertisement which appeared in 
the Montreal Gazette, May 16, 1885.
ing the retirement of Sir Thomas Rod­
dick in 1895, Dr. Bell was appointed 
Surgeon-in-Chief of the Royal Victoria 
Hospital and subsequently, in 1907, 
Professor of Surgery and Head of the 
Department of Surgery at McGill Uni­
versity.
As a man he was quiet, unobtrusive 
and generally modest.7 He was above 
all honest, never a bluffer, and was al­
ways willing to say “ I don’t know.” 
According to his wife he had three 
loves: his profession, his farm and his 
wife . . .  in that order.8 He was a slave to 
work and revelled in it. After a long day 
of surgery at the hospital he would 
often take the electric rail car out to 
his 80-acre farm on the back river and 
tend his prize cattle and horses. He 
called the farm Saraguay, a combination 
of French-Indian for the “ path of the 
raftsman” . At his death his friends 
named the municipality, Saraguay, in 
his honour.
In August 1894 he presented a paper 
to The Canadian Medical Association 
entitled “A Year’s Expeir.ence in Ap­
pendicitis” . In it he clearly spelled out 
that the treatment of appendicitis was 
surgical: “ . . . if recognized early and 
treated surgically the mortality should 
be almost nil. I am fully aware that
in making these statements I am chal­
lenging criticism and unfortunately 
they can neither be confirmed nor re­
futed by statistics for the reason that 
we have no system of vital statistics in 
this Country.”
He goes on to say “ . .. as for the 
treatment of appendicitis, this disease 
should be considered a surgical one 
from the very onset. There is no medical 
treatment for appendicitis. It is a local 
condition which cannot be reached by 
drugs and whose progress cannot be 
materially modified, much less stayed, 
by local application. It is in every case 
a choice between an operation for radi­
cal cure or palliative treatment, which 
means practically leaving the patient to 
his fate.”3 “ . . . I would say, therefore, 
in every case of considerable severity, 
remember the danger of perforation 
and operate. When perforation occurs 
you will have no choice, and in most 
recurrent cases, perforation will occur 
sooner or later. When in doubt, operate, 
and even in the later stages when it 
seems almost hopeless do not be de­
terred from operating.”
Remember, this was in the same sum­
mer that McBurney’s famous article ap­
peared, defining the incision that bears 
his name.9 Actually this incision could 
just as easily have been called “ Bell’s in­
cision” but, in his humble description 
that lacks the elaborate and attractive 
geometry of McBurney’s, he says, 
“ Technique—but little need be said of 
the technique employed in the opera­
tion. The incision was made outside the 
sheath of the rectus muscle, in the line 
of the fibres of external oblique, higher 
or lower according to the apparent site 
of the appendix, and of sufficient length 
to enable the operator to complete the 
operation with the greatest ease.”3
Remember, too, that such a clear out­
spoken statement as to surgical plan 
was not generally accepted. Many 
famous surgeons presented conflicting 
views as to when and on whom operation 
was required. The European surgeons 
favoured a conservative approach. Sir 
Frederick Treves10 said it was rare to
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operate before the first five days of ill­
ness and subsequently went on to 
drain King Edward VII’s appendiceal 
abscess in a room at Buckingham 
Palace,11 thus delaying the King’s coro­
nation.
It was a time when the famous sur­
geon, Fowler, advocated a semi-recum­
bent position for acute appendicitis 
(Fowler’s position). He subsequently 
went on to develop acute appendicitis 
and supposedly died in this posture 
from the complications of postoperative 
ileus.
In all fairness it was also a time when 
the diagnosis was harder to make, be­
cause typhoid fever, tuberculous ileitis 
and dysentery were common differen­
tial diagnoses to entertain.
Despite Dr. Bell’s clear understand­
ing of acute appendicitis and the best 
way to treat it, it appears that he prob­
ably had not convinced his colleagues.
There is some confusion as to what 
happened during Dr. Bell’s terminal 
illness. The records of his hospitaliza­
tion have been lost. Of certainty we 
know his illness lasted six to eight days 
and that he died of the consequences of 
unoperated appendicitis. The full autop­
sy report is not available but the gross 
autopsy findings are listed on a filing 
card in the Institute of Pathology, Mc­
Gill University. It lists the following: 
appendicitis, 2 fecaliths, perforation at 
base, local retrocecal abscess, pleural 
effusion left chest.
He apparently took ill with a malaise 
for a day or so and was in bed at his 
home, 873 Dorchester Street West. 
There was no nausea, vomiting or pain. 
He had lost his appetite. On the third 
day some of the Faculty were called in 
to attend, with no conclusive diagnosis 
forthcoming. Dr. Francis J. Shepherd, 
Consultant Surgeon at the Montreal 
General Hospital was in attendance. Dr. 
Charles Martin, his physician, was out 
of town. On the third day there must 
have been enough concern and suffi­
ciently marked abdominal findings to 
necessitate the patient’s admission to 
the Royal Victoria Hospital for an ex­
ploratory laparotomy. He is said to have 
told his sister-in-law “ Oh! they are 
going to open up my belly!”8
Joseph Wray,* who ran the first 
Canadian ambulance service and a man 
on whom Dr. Bell had recently operated 
for appendicitis, was called to transport 
him to the hospital in a horse-drawn 
ambulance. Something must have al­
tered the “Attending’s” plans because 
the laparotomy was never performed. 
In his monograph “ The Origin and His­
tory of the Montreal General Hospital” 
Dr. Shepherd has written that Dr. Bell 
died refusing operation. On the other 
hand one of the residents, Dr. Gillis,12 
states that Dr. Bell did not refuse opera­
tion, and that he had an acute abdomen. 
Dr. Gillis declares that he assisted at 
the operation. Another report7 records 
that the patient had a retrocecal gan­
grenous appendix causing acute toxemia 
without clear localizing signs.
One probably has to discount the re­
port of the resident, since the appendix 
was found at autopsy. Dr. Francis 
Shepherd, who was in attendance, is so 
succinct in his statements that one 
wonders if he was covering for a missed 
diagnosis, since it is so contrary to the 
words Bell’s sister-in-law attributed to 
him. One wonders if because of the pa­
tient’s seniority and position that he 
may have been included in the decision, 
making it more difficult to follow a 
clear course. The other possibility is that 
because of the practice in regard to 
appendiceal surgery at the time it was 
hoped the signs would localize and an 
“ interval” type of operation could be 
performed.
On the eighth day, with his wife, son 
and sister-in-law in attendance, the pa­
tient died with his son’s name “ Stuart”  
on his lips.
The sole purpose of this communica­
tion is to recount the sad irony of Dr. 
Bell’s terminal illness. Other interpreta­
tions are obvious and are left to the 
reader.
The author is grateful to the late Mrs. R. E. 
MacDougall, and the late Dr. R. R. Gillis for
*W ray Funeral Service, a respected family- 
business in Montreal.
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their personal reminiscences. The Montreal 6. 
Gazette and the Public Archives, Ottawa were 
very helpful. Dr. S. Salisbury’s help is also
appreciated. 7.
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REVIEW ARTICLE
THROMBOSIS ON PROSTHETIC SURFACES:
A REVIEW OF ETIOLOGIC FACTORS AND PREVENTIVE MEASURES*
ERIC D. FOSTER, M.D., MARY R. SMITH, M.D. and 
ANTHONY R. C. DOBELL, M.D., Montreal, Que.
“When blood is received into a cup and is 
thereby exposed, it certainly coagulates 
more rapidly than when extravasated in 
the cellular membrane or in the vessels: 
and on the exposed surfaces it coagulates 
more rapidly than anywhere else, except 
around the edges of the dish in which it 
is contained.”
John Hunter 1728 to 1793
B io lo g ical  response to foreign mate­
rials has come under increased study 
in recent times as a result of dramatic 
advances in the construction and use of 
prosthetic materials. The bodily re­
sponses to these materials have been as 
diverse as degradation, inflammation 
and thrombosis. In this context the re­
sponse of blood to foreign surfaces is 
of particular interest because of the 
widespread use of prosthetic materials 
in cardiovascular surgery. Despite in­
tensive efforts by a number of investi­
gators, the problem of incompatibility 
between blood and foreign surfaces re­
mains unsolved.
Over two centuries ago John Hunter 
recognized the effect of a foreign sur­
face on the coagulation of blood. At the 
present time, thrombosis on prosthetic 
surfaces is an impediment to further 
progress in the following areas of car­
diovascular surgery: (a) prosthetic re­
placements for small-diameter arteries 
and venous segments, (b) prosthetic 
heart-valve replacements and (c) de­
velopment of a workable artificial heart. 
An evaluation of patency rates for 
prosthetic vascular grafts reveals a 
high incidence of failure due to throm­
bosis ; this is particularly prevalent with 
venous replacement.1-4 Recognizing the 
role of platelets in initiating graft 
thrombosis, Evans and Mustard5 have 
correlated characteristics of individual 
patients’ platelets and duration of pro-
*From the Departments of Surgery and Hema­
tology, Royal Victoria Hospital and McGill 
University, Montreal, Que.
sthetic arterial graft patency. In spite 
of careful anticoagulation, thrombus 
formation on prosthetic cardiac valves 
remains the most serious late complica­
tion clouding the prognosis of patients 
undergoing cardiac valve replacement.6,7 
The development of thrombi on pros­
thetic valve surface with the danger 
of embolization has been discussed by 
many observers.8'11 Brewer,12 reporting 
on the combined statistical series of sev­
eral medical centres totalling more than 
1000 heart valve replacements, found 
the incidence of fatal embolization to be 
4% and non-fatal embolization 8% post- 
operatively. An artificial heart for hu­
man application awaits development o f 
a satisfactory non-thrombogenic ma­
terial. In addition to its non-thrombo- 
genic characteristic, the material called 
for by most artificial heart designs 
must be flexible.13,14
T h r o m b u s  F o r m a t io n  o n  a  
P r o s t h e t ic  S u r f a c e
Virchow first suggested the im­
portant triad of factors leading to 
thrombosis: (1) hypercoagulable blood 
factors, (2) stasis of flow, and (3) loss 
of the normal vascular lining.
By itself any one of these factors will 
not produce thrombosis generally; how­
ever, a combination of any two factors 
will lead to thrombus formation. Con­
sidering this triad, it is not surprising 
that thrombosis occurs on prosthetic 
material introduced into the blood 
stream. The surgical procedure to in­
stall the prosthetic device can produce 
hypercoagulable blood factors; despite 
advances in design to streamline flow 
through a prosthesis, there remains 
some stasis in most artificial devices; 
and prosthetic surfaces at present are 
“ foreign” when compared to the normal 
vascular lining. In addition to the three
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Fig. 1.—Simplified diagram showing current concepts of blood coagulation.
factors suggested by Virchow, tur­
bulence is recognized now as important 
in initiating and propagating prosthetic 
thrombosis.
Although progress in prevention of 
clotting on prosthetic surfaces has been 
limited, knowledge of the various stages 
of clot formation has expanded rapid­
ly.1517 Fig. 1 shows the current concepts 
o f  blood coagulation as described by 
Marcus.18 The “ right-hand pathway” is 
the mechanism for clotting that prob­
ably occurs on an intravascular prosthe­
tic surface; the “ left-hand pathway” de­
scribes the formation of a thrombus in 
an area of tissue injury. Blood-coagula­
tion studies on foreign surfaces have 
been carried out under direct observa­
tion in static conditions using glass test 
tubes, and in a flowing state using ex­
tracorporeal shunts.19,20 With blood-pro­
sthetic surface contact, clotting seems 
to be initiated by the immediate adsorp­
tion of Hageman protein (Factor XII) 
on the foreign surface with activation 
of this factor. Activated Hageman pro­
tein, in turn, activates plasma thrombo­
plastin antecedent (Factor XI) ; with a 
cascading effect there is rapid activa­
tion of the other clotting proteins and 
the generation of intrinsic prothrombin 
activator. Intrinsic prothrombin activa­
tor converts prothrombin to thrombin 
which, in turn, converts fibrinogen to 
fibrin. Fig. 2 summarizes these clotting 
events on a polymer surface in relation 
to the duration of blood-surface contact. 
While most prosthetic thrombosis is 
generated through mechanisms of the 
“ right-hand pathway” (Fig. 1), the 
“ left-hand pathway” undoubtedly con­
tributes to the production of thrombus, 
particularly that occurring at the pros­
thetic-endothelial junction where trau­
ma produces sufficient “ tissue factor” 
to activate the extrinsic system.21
E t io lo gic  F a c t o r s
In an attempt to find the causes of 
prosthetic thrombosis, investigators
CONTACT
PROTEINS (? XII, XI) 
ABSORBED AND 
ACTIVATED
PROTH. ACT.
PROTHROMBIN — * — » -  THROMBIN
POLYMER A TIMEAFTER
IMPLANT
P L A T E L E T S < *
AGGREGATE
' m
Fig. 2.—A scheme for thrombogenesis on 
polymer surfaces.
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have studied the physical properties of 
the prosthetic surfaces and compared 
them to the physical properties of the 
normal vascular lining.
The following physical properties 
have been of particular interest: (a) 
smoothness, (b) wettability, (c) elec­
trical charge, and (d) zeta potential. 
Smoothness of the vascular intima was 
considered important in preventing in­
travascular clotting; however, there are 
numerous reports of thrombosis of 
smooth vascular grafts.5, 22, 23 Dreyer, 
Akutsu and Kolff23 found that a rough 
prosthetic surface seemed to be an ad­
vantage because it soon acquired a fib­
rinous covering which evolved into a 
smooth layer resembling the endothe­
lium. The roughness of a prosthetic sur­
face becomes important if it produces 
turbulence in blood flow across it. The 
vascular wall is hydrophilic, thus it 
would seem that the ideal prosthetic in­
travascular material would be hydro­
philic also.24 However, many of the best 
thromboresistant surfaces produced 
thus far, such as siliconized glass and 
polyvinyl pyrrolidone surfaces, are hy­
drophobic. Vroman17,25 has studied ad­
sorption of various clotting proteins on 
hydrophobic and hydrophilic surfaces: 
Factors XI, VIII, V and thrombin and 
fibrinogen are hydrophobic proteins 
and would be readily adsorbed by hydro- 
phobic materials; Factors XII, IX, X 
and prothrombin and fibrin tend to be 
hydrophilic proteins adsorbed by hydro­
philic surfaces. In 1927 Abramson28 de­
monstrated that all blood cells are neg­
atively charged at the pH of blood and 
move toward the positive pole in an 
electrophoretic cell. Sawyer and Pate,27 
in 1953, demonstrated a similar neg­
ative charge on the blood vessel wall; 
they found that the undamaged intima 
of the aorta is normally negative with 
respect to the adventitia with a poten­
tial difference in the range of -1 to -5 
millivolts, and with trauma to the in­
tima this polarity is reversed. Most 
polymers have a negative charge on 
their surfaces ranging from -8 to -25 
millivolts in the presence of a flowing 
saline solution. In the past, many work­
ers thought to develop a non-thrombo- 
genic surface with polymers because of 
the mutually repulsive charges on the 
polymer surface and the platelets, red 
blood cells and leukocytes. However, 
with most negatively charged polymers 
the surface charge quickly approaches 
zero as plasma is passed over it; this is 
most likely owing to the rapid adsorp­
tion of plasma proteins on to these sur­
faces.28 Nevertheless, thrombosis is in­
hibited by an electronegative field.29,30 
Work continues to develop a thrombo­
resistant surface that will either re­
tain its negative charge after being ex­
posed to plasma, or a surface that will 
develop a negative charge after contact 
with blood.31 The zeta potential, an elec- 
trokinetic phenomenon, involves relative 
motion between a charged surface and 
a bulk solution. When the solid surface 
is stationary as with the intima, the 
potential induced by the flow of blood 
is called a streaming potential. Strictly 
speaking it is not a phase-boundary po­
tential because it is developed wholly 
within the fluid region. The plane of 
slip lies between the double layer of 
ions adsorbed on the surface and the 
fluid medium. The zeta potential is 
highly negative in thromboresistant 
surfaces but depends on the electric 
charge on the prosthetic surface. There­
fore, with most polymer surfaces, the 
zeta potential approaches zero rapidly 
with exposure to blood, secondary to the 
deposition of protein on the plastic sur­
face.28
In reviewing the findings of many in­
vestigators concerning the importance 
of various physical properties of pros­
thetic surfaces and their thromboresist- 
ance, it is clear there are divergent 
views. Duplication of the normql vas­
cular lining is far from possible. In fact, 
none of the usually measured physical 
characteristics of prosthetic surfaces 
such as smoothness, wettability, electric 
charge and zeta potential may have a 
direct influence upon its compatibility 
with blood.32 At present the chemical 
nature of the surface appears to be of 
overriding importance.
An important chemical property of
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normal vascular endothelium is that 
it contains an anticoagulant acid muco­
polysaccharide. Many research workers 
have attempted to duplicate this chem­
ical feature in their search for a non- 
thrombogenic surface. The ground sub­
stance and tissue mast cells of vascular 
endothelium are rich in acid mucopoly­
saccharides ; specific components in­
clude chondroitin sulfates A and B, hya­
luronic acid and heparitin sulfate.33'35 It 
has been shown that the mucopolysac­
charide extract of human aorta, 0.5% 
by weight, displays anticoagulant prop­
erties which can be neutralized with 
protamine sulfate. The active mucopoly­
saccharide has been identified as chon­
droitin sulfate B.33 McGovern36 demon­
strated in vivo the surface anticoagulant 
effect of endothelial ground substance 
as it spread out over injured endothe­
lium after trauma. To date, one of the 
most successful non-thrombogenic sur­
faces is the graphite-benzalkonium 
chloride-heparin (GBH) surface de­
veloped by Gott, Whiffen and Dutton.37 
Heparin, an acid mucopolysaccharide, is 
a close chemical relative to chondroitin 
sulfate B.
While we lack knowledge about the 
precise physicochemical process that 
initiates clotting of blood on a prosthe­
tic surface, there is considerable his­
tologic evidence concerning the type of 
thrombus formed. The initial lesion that 
develops on prosthetic devices is the 
“ white-thrombus” , which consists main­
ly of platelets, strands of fibrin and oc­
casional leukocytes. If the platelet mass 
enlarges to the point where it becomes 
occlusive and stasis develops then the 
“ red thrombus” may develop behind the 
platelet mass; it is composed of erythro­
cytes, leukocytes, fibrin and platelets 
distributed in a random fashion. White 
thrombi are seen in high-blood-flow 
states while red thrombi are found 
primarily in static, low-blood-flow 
states. Several groups of investigators, 
who studied the formation of thrombi 
in plastic extracorporeal shunt systems, 
found that the platelet is the earliest 
and only invariable component of these 
thrombi.19,20
Role of the Platelet in 
Prosthetic T hrombosis
The interaction of platelets with pros­
thetic surfaces is one of the most im­
portant stimuli in the initiation of 
thrombosis.38 , 39 In vivo platelets exist 
as non-nucleated disc-shaped “ cells” , 2/x 
to 3/tx in diameter surrounded by blood 
plasma. Although Bizzozero,40 in 1882, 
recognized the role platelets played in 
thrombus formation, more detailed 
studies of platelet function could not 
be made until introduction of the elec­
tron microscope. These tiny formed ele­
ments may alter their size, shape and 
biochemical composition in response to 
environmental changes. At present 
there seem to be three distinct stages in 
the platelet response to a prosthetic sur­
face leading to the platelet mass or 
white thrombus formation. These are: 
(a) adherence of platelets to the sur­
face leading to release of platelet con­
stituents, (b) aggregation of platelets 
induced by adenosine diphosphate 
(ADP), and (c) thrombin production 
causing further platelet aggregation, 
release of platelet constituents, and 
fibrin formation around the periphery 
of the platelet mass.5
It remains unclear how a prosthetic 
surface differs from the normal vas­
cular lining thereby stimulating cir­
culating platelets to adhere to it, but the 
stimulating factor is probably chemical 
rather than a physical property of the 
prosthetic surface. One theory for the 
triggering of platelet adhesion to pros­
thetic surfaces holds that the platelet’s 
plasma membrane contains a phospholi- 
poprotein which is readily adsorbed by 
most plastic surfaces. Once the surface 
has adsorbed the phospholipoprotein, 
Hageman protein can be adsorbed and 
activated, leading to activation of the 
intrinsic system and platelet adhesion.1 
Another explanation is based on the fact 
that some 15 platelet proteins have been 
identified including coagulation Factors 
V, X, XIII, and Hageman protein ad­
sorbed on the plasma membrane.18 Ad­
sorption of these platelet proteins on to 
the prosthetic surface may lead to their
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activation and platelet adhesion. Ad­
herence of platelets to the prosthetic 
surface leads to release of their consti­
tuents—serotonin, histamine and ade­
nine nucleotides (ATP and AD P).15
When platelets are exposed to ADP 
they change from their characteristic 
disc shape to a more rounded form with 
pseudopods, and they adhere to one an­
other—a phenomenon termed “ platelet 
aggregation” .41 This ADP-induced ag­
gregation of platelets on to the prosthe­
tic surface depends upon the presence 
o f calcium ions, and metabolic energy 
is involved.42,43 Initially, the principal 
source of ADP is thought to be that re­
leased from platelets adhering to the 
prosthetic surface; however, erythro­
cytes have a high content of ADP and 
many contribute to the total amount 
available if significant hemolysis is 
present.44 ADP-platelet aggregation is a 
reversible process: following deaggre­
gation they quickly return to their ori­
ginal disc shape.15 The extent of aggre­
gation and the stability of the platelet 
aggregates are related to the amount of 
ADP available and the speed at which 
it is dephosphorylated. Once ADP is lost 
from the fluid surrounding the platelets, 
they deaggregate unless fibrin is 
formed to stabilize the mass.45
With activation of the “water fall” 
sequence of the intrinsic coagulation 
system (Figs. 1 and 2), thrombin is 
rapidly formed in the area of the plate­
let aggregates at a rate faster than it 
can be diluted by flowing blood and neu­
tralized.15 Platelet membrane phospholi- 
poprotein functions at two stages in the 
development of intrinsic prothrombin 
activator to which it supplies a catalytic 
surface for the interaction of the plas­
ma coagulation factors (Fig. I ).46' 47 This 
platelet contribution to the coagulation 
process is known as “ platelet-factor 3” 
(P F -3 ): in vivo, this activity appears 
before the formation of thrombin and 
originates from the plasma membrane 
of aggregated platelets. Thrombin pro­
duces two distinct phenomena in throm­
bus formation: (a) the further aggre­
gation of platelets and release of their 
constituents, and (b) conversion of fib­
rinogen to fibrin. In the presence of 
thrombin the entire platelet aggregate 
contracts, an effect probably mediated 
by the contractile platelet protein, 
thrombostenin.48 The aggregation of 
platelets with release of their constitu­
ents and the contraction of the platelet 
aggregate in response to thrombin ap­
pear to be irreversible: it is a part of 
the platelet mass development stage 
known as “viscous metamorphosis” 
where the platelets lose their individual 
identity because there is breakdown of 
plasma membranes and a coalescing of 
all platelet components.40 Thrombin 
causes the conversion of fibrinogen to 
fibrin and activates the fibrin-stabil­
izing factor, Factor XIII.50 Electron mi­
crography has shown that the fibrin is 
laid down initially around the periphe­
ry of the platelet mass, stabilizing it.51
As depicted in Fig. 2, this series of 
platelet events in the formation of a 
white thrombus on a prosthetic surface 
takes place over a short period; the first 
platelets adhere to a foreign surface 
within one minute of exposure to blood, 
by one hour the thrombus is composed 
of aggregated platelets surrounded by 
fibrin, and at one day the thrombus is 
a mass of fibrin with platelet debris 
interspersed among the fibrin fibres.15 
However, it must be kept in mind that 
the amount of thrombus formation is 
highly variable; it depends not only 
upon the thrombogenicity of the pros­
thetic surface, but upon the degree of 
each individual’s coagulation response.
Inhibition of Platelet A dhesion 
and A ggregation
A large number of compounds inhibit 
platelet adhesion-aggregation. Although 
many have proved effective in vitro 
they cannot be used in vivo because of 
toxic side effects.16' 52, 53 Table I provides 
a summary of some of the compounds 
that have demonstrated platelet inhibi­
tion and might be used in vivo. All of 
the substances listed are thought to be 
capable of depressing both platelet ag­
gregation by ADP and the release of 
platelet constituents, except the imipra-
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TABLE I.— Platelet Inhibiting Compounds
Compound, group Examples
Adenine compounds ATP, AMP, adenosine, 
2-chIoroadenosine 
Antihistamines chlorpheniramine
Fibrinogen degradation 
products “ early”  FDP
“ late”  FDP
Imipramine compounds 
Methyl xanthines
Monoamine oxidase 
inhibitors
Non-steroidal anti-in­
flammatory drugs 
Prostaglandins 
Pyrazole drugs
Pyrimido-pyrimidine
compounds
imipramine hydrochloride 
caffeine, theobromine 
aminophylline
nialamide
acetylsalicylic acid
prostaglandin Ej
sulfinpyrazone
phenylbutazone
dipyridamole
RA233*
RA433f
*2, 6-bis(diethylamino)-4-piperidino-pyrimido-(5, 4- 
d) pyrimidine.
f2, 4, 6-trimorpholino-pyrimido-(5, 4-d) pyrimidine.
mine compounds, non-steroidal anti-in­
flammatory drugs, and the pyrazole 
drugs which do not inhibit ADP-in- 
duced platelet aggregation. Many of 
these compounds have, as a common 
denominator, the capacity of vasodila­
tion : for example, adenine compounds, 
prostaglandins and pyrimido-pyri­
midine compounds.54 The role played by 
vasodilation, if any, in platelet inhibi­
tion continues under study. Of the ade­
nine compounds, adenosine and 2-chlo- 
roadenosine have proved effective in 
inhibiting ADP aggregation and plate­
let release reactions. However, both are 
strong vasodilators and may have a 
hypotensive effect in vivo,55 Antihista­
mines decrease platelet adhesiveness 
and. in higher concentrations, inhibit 
the release reaction.56 Fibrinogen degra­
dation products (FDP), particularly the 
“early” FDP fraction, interfere with 
platelet aggregation by ADP and throm­
bin, inhibit the release reaction and de­
crease platelet adhesiveness to glass.57 
The imipramine compounds are consi­
dered to be “ membrane stabilizer” 
drugs when functioning as platelet in­
hibitors; they will block the release of 
platelet constituents including ADP, but 
have no effect on the aggregating ac­
tion of circulating ADP on platelets.58
Methyl xanthines inhibit phosphodies­
terase, an enzyme that normally breaks 
down platelet cyclic AMP: diminution 
in platelet cyclic AMP is associated 
with platelet aggregation.59 Of the 
monoamine oxidase inhibitors, niala­
mide has been demonstrated to inhibit 
platelets when given to humans in doses 
of about 3 mg,/kg. body weight.52 Non­
steroidal anti-inflammatory drugs in­
clude acetylsalicylic acid and the pyra­
zole drugs; these compounds have been 
studied intensively by Packham et aZ.60'62 
who have demonstrated that these sub­
stances inhibit the platelet release reac­
tion. Prostaglandin E is the most potent 
inhibitor of platelet aggregation in 
vitro, but its use in vivo may be limited 
because of its vasodilator effect.63 Of 
the pyrimido-pyrimidine compounds, 
dipyridamole has undergone the most 
study. It inhibits ADP-induced platelet 
aggregation and the platelet release re­
action, as well as promoting deaggrega­
tion of human platelets in vitro.64 En­
couraging clinical results have been re­
ported with the use of dipyridamole in 
preventing thromboembolic complica­
tions among patients after cardiac valve 
replacement.65 Dipyridamole and two 
related compounds, RA233 and RA433, 
are potent vasodilators in addition to 
being platelet inhibitors. Of the three, 
RA433 seems to produce the greatest 
platelet inhibition per milligram with 
the least vasodilation.66
Although there are contradictory re­
ports concerning the effect of anti­
coagulants on platelet function, these 
substances probably have little direct 
effect on platelet adhesion, aggregation 
and the release reaction. Oral anticoa­
gulants such as dicoumarol do not affect 
platelet adhesiveness as judged by in 
vivo animal tests; with extracorporeal 
shunts, platelet thrombi could not be 
prevented even when doses of dicouma­
rol were used sufficient to prolong the 
prothrombin time to over 60 seconds.67 
Heparin combines reversibly with Fac­
tor IX, preventing further progress of 
the “ water fall” coagulation sequence 
(Fig. 1 ): it blocks prothrombin activa­
tion preventing the formation of throm-
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bin.68 Thus heparin’s action on platelet 
function is indirect; it acts by reducing 
thrombin activity. High doses of hepa­
rin, much above those conventionally 
used for an anticoagulant effect, can in­
hibit platelet response to ADP.69
Review  of N on -thrombogenic 
Surfaces
Freund, in 1903, observed that coat­
ing of glassware with vaseline pro­
longed the clotting time of blood; this 
is believed to be the earliest report of 
an attempt to modify a foreign surface 
in contact with blood. In the same year, 
Bordet and Gengou70 found that the 
clotting time could be prolonged by coat­
ing glass with paraffin. The next major 
event in thromboresistant-surface re­
search came in 1930 when Lampert71 
stated that the ability of a surface to 
delay the coagulation of blood was pro­
portional to the capacity of that surface 
to repel water (Lampert’s Rule). Sur­
face wettability underwent further stu­
dy and, in 1949, Donovan and Zimmer- 
mann72 expressed the view that water 
repellence was a major, but not the sole, 
factor in the ability of a surface to pre­
vent clotting. In 1951 a surface of poly­
styrene sodium sulfonate was prepared 
in an effort to simulate the polysac­
charides of the intima; it was found 
that this surface markedly prolonged 
in vitro clotting times and its negative 
charge was believed to be of prime im­
portance.73 As has been stated, present 
research indicates that surface wet­
tability and electric charge have little 
influence on determining blood com­
patibility.32
The search for a non-thrombogenic 
surface gained impetus following the 
development in 1953 by Hufnagel and 
Harvey of a prosthetic aortic valve 
made of plexiglass. Interest in silicon­
ized surfaces arose following reports in 
1954 that siliconized glass was the best 
material for delaying the clotting of 
blood.74 In 1961 Ross et al.7i reported on 
their evaluation of the thromboresistant 
properties of 30 commercially available 
polymers; they found several, such as
polyvinyl pyrrolidone and silicone rub­
ber, that showed resistance to throm­
bosis significantly greater than that of 
siliconized glass.
One of the most important findings in 
the search for a thromboresistant sur­
face was made in 1961 when Gott et al. 
76 found that a methyl methacrylate sur­
face coated with colloidal graohite was 
highly resistant to thrombus formation 
in vivo. Initially it was believed that 
this surface’s smoothness and inertness 
inhibited blood clotting. However, it 
was demonstrated that graphite’s most 
important anticoagulant property was 
the ability to bond heparin to its sur­
face. Subsequent work by Gott showed 
that a higher surface concentration of 
heparin could be obtained if the gra­
phite was rinsed with a cationic sur­
face-active agent, benzalkonium chlo­
ride, before exposure to heparin.37 The 
result of this work was the “ GBH sur­
face” , or graphite-benzalkonium-hepa- 
rin surface. By incorporating heparin 
this surface has an acid mucopolysac­
charide similar to that found in the 
normal intima. Present evidence in­
dicates that the thromboresistance of 
GBH surfaces is owing to the fact that 
a heparinized surface has the ability to 
bond both unactivated and activated 
Hageman factor tightly so that the lat­
ter substance cannot be released in com­
bination with Factor XI (PTA) (Fig. 
1) and thus initiate the “water fall” 
clotting sequence with eventual conver­
sion of fibrinogen to fibrin.77 It*is of 
interest to note that the GBH surface is 
moderately wettable and has a negative 
surface potential, even after exposure to 
blood, two more similarities with nor­
mal intima. Good stability of a GBH 
surface in vivo has been demonstrated 
using 35S heparin; 20% of the original 
activity was present after three months 
of exposure to the blood stream.78 Of 
further interest is that GBH surfaces 
will retain their clot-repellent ability 
in vivo despite intravascular infusions 
of protamine sulfate.79 Clinically, GBH- 
coated shunts have been used successful­
ly for aortic bypass in the elective re­
section of descending thoracic aortic
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aneurysms.80 As promising as the GBH 
surface appears, it has one important 
shortcoming, namely, it cannot be ap­
plied to flexible surfaces because of the 
graphite.
At the present time many of the non- 
thrombogenic materials being developed 
by investigators throughout North 
America are sent to Dr. V. L. Gott at 
the Johns Hopkins Medical Center for 
evaluation. Dr. Gott has undertaken 
this task in conjunction with the Na­
tional Heart and Lung Institute in the 
United States. The following analysis 
of non-thrombogenic surfaces is based 
on Dr. Gott’s progress reports to the 
N.H.L.I.81 The materials evaluated can 
be classified into three groups: (a) 
heparinized surfaces, (b) surfaces with 
ionic radicals or imposed electrical 
charges and (c) surfaces of relatively 
inert materials. Figs. 3 to 5 provide
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Fig. 3.—Heparinized surfaces undergoing 
evaluation for thromboresistance.
examples of each of these three groups. 
The goal of those seeking to develop a 
heparinized surface is to achieve all the 
favourable points of the GBH surface 
but, additionally, to have flexibility. De­
spite mounting evidence to the con­
trary, many investigators continue to 
seek to develop a thromboresistant sur­
face by imparting to it an electrical 
charge. The degree of the thrombore­
sistance seen with these charged sur­
faces probably depends more upon 
the chemical nature of the surface. 
Developers of inert materials seek to 
achieve blood compatibility by creating 
a surface that will not activate the clot­
ting proteins of the intrinsic coagula­
tion system. Some favourable results 
have been found with in vivo tests of 
these materials, particularly those in 
groups (a) and (c). A favourable factor 
concerning the heparinized surfaces is
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Fig. 4.—Surfaces with ionic radicals or im­
posed electrical charges.
that they seem to have more initial 
thromboresistance. However, unfavour­
able factors are that heparin can gradu­
ally be depleted from the surfaces and 
heparinized materials seem to bind 
large quantities of lipid which can 
structurally weaken many surfaces. A 
favourable factor concerning the non- 
heparinized materials, groups (b) and 
(c), is that they may have a more stable 
surface over long periods of implanta­
tion. Unfavourable factors are that 
hydrated and protein-coated surfaces 
cannot dry out during insertion of the 
prosthesis and some of these coatings 
are difficult to bond to underlying ma­
terials.
Bernhard et al,82 and others83 sought to 
develop biologic thromboresistant ma­
terials by enhancing pseudoendotheliali- 
zation on surfaces of intravascular 
prosthetic devices by seeding them with 
fetal fibroblasts grown in tissue cul­
tures. With a covering of pseudoendo­
thelium, prosthetic materials can no 
longer activate blood coagulation fac-
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rials.
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tors by contact mechanisms. In animal experiments with polyurethane surfaces flocked with Dacron fibrils and seeded with bovine fetal fibroblasts, pseudoen- dothelialization on these surfaces in­creased compared with control materials when used in large calibre arterial grafts, ventricular assist devices and to­tal artificial hearts.84 However, complete pseudoendothelialization of a surface may take days, even with a fibroblast- impregnated material, necessitating sys­temic anticoagulation immediately fol­lowing implantation of the fibroblast- coated device. The possibility of immu­nologic rejection of allogenic fibroblasts must be evaluated also.Despite the efforts of many workers, a totally satisfactory non-thrombogenic material that is durable and flexible has not yet been developed.
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R e su m e
La thrombose declenchee par une prothese 
intravasculaire demeure une des grandes com­
plications de la chirurgie cardiovasculaire. Les 
mecanismes de la coagulation, tels qu’on les 
connait actuellement, sont rappeles avec atten­
tion, notamment ceux qui concernent la forma- • 
tion et la propagation des thrombus sur la sur­
face des protheses. Les auteurs soulignent le 
role des plaquettes dans la thrombogenese, 
rappellent la fonction des plaquettes et discu- 
tent les merites des agents antiplaquettaires 
connus. Ils brossent un bref historique des ten- 
tatives faites pour modifier les surfaces des 
protheses artificielles, en vue de prevenir la 
thrombose. Malgre les enormes efforts de nom- 
breux chercheurs, la surface athrombogene 
ideale reste encore a decouvrir.
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TRAUMATIC RUPTURE OF THE THORACIC AORTA*
S. R. KRISHNA IYENGAR, M.B., B.S., F.R.C.S.[C], EDWARD J. P. CHARRETTE, 
M.D., F.R.C.S.[C], F.A.C.S., R. BEVERLEY LYNN, M.D., F.R.C.S.(Eng. & Edin.), 
F.A.C.S. and RICHARD McARIHUR, M.D., F.R.C.S.(Edin.), Kingston, Ont.
On reviewing 194 patients with automo­
bile chest injuries, Molnar and Face1 
found that 25% sustained major in­
juries of intrathoracic organs and 3.5% 
had rupture of the thoracic aorta. For 
this reason the surgeon should suspect 
traumatic rupture of the aorta in all 
patients with blunt chest trauma.
About 80% of patients with trauma­
tic aortic rupture die of massive hemor­
rhage before reaching a hospital.2 Of 
the remaining 20%, four-fifths live for 
a few hours to three weeks before fatal 
bleeding occurs. Finally, of such pa­
tients, one in 20 who have no evidence 
of aortic injury at the time of accident 
develops an aortic aneurysm months or 
years later.
Recent diagnostic and technical ad­
vances have made it possible to salvage
•From the Division of Cardiovascular and 
Thoracic Surgery, Queen’s University, King­
ston, Ont.
some of the patients who survive for a 
few hours or longer, if the lesion is 
diagnosed and accurately located angio- 
graphically and the patient is taken to 
the operating room at once.
This paper describes our experience 
with seven patients with traumatic rup­
ture of the thoracic aorta. These cases 
illustrate some salient features of the 
pathophysiology, natural history, clini­
cal presentation and surgical manage­
ment of this condition.
Case  R eports
Case 1.— J.T., a 28-year-old white man, 
was admitted to the Kingston General Hos­
pital on August 30, 1967 with the com­
plaint of “bursts” of sharp pain in his right 
subcostal region. Ten years earlier he had 
sustained multiple injuries, including chest- 
wall and lung contusion, in an automobile 
accident and had been unconscious for a 
month. His blood pressure was 138/66 mm.
Fig. la Fig. lb
Fig. 1.—Case 1. (a) Posteroanterior radiograph showing widened aortic arch with a rim 
of calcium, (b) Transbrachial aortogram showing saccular aneurysm distal to the left sub­
clavian artery.
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Hg in the right arm and 124/64 in the left 
arm, his pulse was 80/min. and regular, 
and he had a grade 1 to 2 systolic ejection 
murmur loudest at the second left inter­
costal space. All the peripheral pulses were 
normal. The chest radiograph showed un­
folding of the ascending aorta and widening 
of the arch with a rim of calcium (Fig. la). 
An aortic arch angiogram showed a sac­
cular aneurysm distal to the left subclavian 
artery (Fig. lb ). When a left thoracotomy 
was performed on November 1, 1967 we 
found a saccular aneurysm with a broad 
base. The wall was heavily calcified and 
since there were no detectable areas of 
weakening prone to rupture, the planned 
resection was abandoned. The patient re­
mains well five years later.
Case 2.— L.S., a 75-year-old white woman, 
was admitted at 5:30 p.m. on July 20, 1970 
with multiple injuries sustained in a motor 
vehicle accident. She was alert and con­
scious but complained of lancinating pain 
in the back. There was paradoxical motion 
of the left chest and she was tender in the 
parascapular area. There was diminished 
air entry over the whole left lung field with 
the presence of moist rales. The left second 
to seventh ribs were fractured. A poorly 
defined shadow over the left lung field sug­
gested either lung contusion or hemothorax 
(Fig. 2a). Her pulse was 80/min. and her 
blood pressure was 135/80 mm. Hg. Intra-
Fig. 2.—Case 2. (a) Pulmonary contusion or 
left hemothorax— 6:00  p.m. July 20, 1970. 
(b) Possible widening of the superior media­
stinum in addition to left hemothorax —  8:00  
p.m. the same day. (c) Further mediastinal 
widening 20 minutes later. This was followed 
immediately by sudden drainage of a large 
volume of blood through the intercostal tubes, 
and death.
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Fig. 3.—Case 2. Transverse tear of the aorta 
(1) distal to the left subclavian artery (2). A  
periaortic hematoma can be seen through the 
tear.
venous fluids were started and an endo­
tracheal tube was inserted to assist respira­
tion with a Bennett respirator. Apical 
anterior and posterolateral chest tubes were
inserted into appropriate intercostal spaces 
and 200 ml. of blood was evacuated from the 
pleural cavity. Her vital signs remained 
stable. At 8:00 p.m. another supine portable 
chest film (Fig. 2b) showed possible widen­
ing of the superior mediastinum and this 
increased markedly over the next 20 min­
utes (Fig. 2c). At that time 1000 ml. of 
blood suddenly drained from the chest 
tubes and the patient went into shock. In 
spite of rapid blood transfusions she died 
within a few minutes. Autopsy showed a 
transverse tear of the aortic isthmus distal 
to the left subclavian artery (Fig. 3).
Case 3.— N.M., a 22-year-old student 
nurse, sustained craniocerebral injuries, 
pulmonary contusion, multiple lacerations 
and a fracture of the left olecranon in an 
automobile accident in August 1967. Treat­
ment included tracheostomy and controlled 
ventilation. The fracture required internal 
fixation. She recovered and was discharged 
on August 25, 1967. Three months later she 
felt something “ snap” in her chest while 
playing basketball. A chest film at this 
time showed a change in the contour and 
prominence of the aortic arch (Fig. 4). 
An aortogram demonstrated an aneurysm 
of the thoracic aorta distal to the left sub­
clavian artery (Fig. 5). On January 25, 
1968, at left thoracotomy, an hourglass-
Fig. 4a Fig. 4b
Fig. 4.—Case 3. Posteroanterior chest roentgenograms (a) normal before injury, (b) 
bulging aortic arch three months after injury.
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Fig. 5.—Case 3. Aortogram showing a false 
aneurysm at the aortic isthmus.
shaped false aneurysm five inches in length 
was found just distal to the left subclavian 
artery. There was almost total transection 
of the aortic wall necessitating the insertion 
of a tubular Dacron graft using femoro- 
femoral partial bypass. She recovered un­
eventfully and remains well more than five 
years later.
Case U-— F.S., a 26-year-old white man, 
was admitted to the Kingston General Hos­
pital emergency department on November 
15, 1968 after an automobile accident. He 
was conscious but somewhat disoriented. 
Except for a laceration of the left ear, there 
were no signs of external injury. His pulse 
was 80/min. and regular, and his blood 
pressure was 160/80 mm. Hg. On physical 
examination the findings were within nor­
mal limits. A chest film showed a large 
mediastinal mass which displaced the 
trachea to the right (Fig. 6). An aortic 
arch angiogram showed a tear of the 
thoracic aorta d'stal to the left subclavian 
artery (Fig. 7). Under femorofemoral par­
tial bypass we resected the false aneurysm 
and restored the continuity of the aorta 
with an interposed Teflon graft. The pa­
tient required tracheostomy and ventilatory 
support because of bilateral pulmonary 
contusion which became evident in the post-
Fig. 6.—Case 4. Large superior mediastinal 
mass displacing the trachea to the right.
operative period. He remains completely 
asymptomatic four years later.
Case 5.—C.D., a 48-year-old man, sus­
tained multiple injuries in an automobile 
accident on July 15, 1970. He was seen in 
an outlying hospital in a state of shock 
from chest and intra-abdominal injuries 
and a comminuted fracture of the left 
femur. Chest radiograph showed a widened
Fig. 7.—Case 4. Aortogram showing a peria­
ortic hematoma in the region of the tear.
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mediastinum and fracture of ribs on the 
left side. After resuscitation he was trans­
ferred to the Kingston General Hospital 
and, on arrival, his blood pressure was 
stable and his pulse was 80/min. On aortic 
arch angiography the dye extravasated 
distal to the left subclavian artery. He had 
abdominal rigidity and rebound tenderness 
and on the angiograms his spleen was dis­
placed suggesting splenic rupture.
A laparotomy was carried out first. The 
ruptured spleen was removed and hemor­
rhage from a tear in the mesentery was 
controlled. After this operation was com­
pleted he was placed on femorofemoral 
partial bypass and a left thoracotomy per­
formed. The aortic tear involved one-half of 
its circumference just distal to the sub­
clavian artery. It was possible to approxi­
mate the divided edges of the aorta so that 
a prosthetic graft was not required.
His postoperative course was stormy be­
cause he had a number of complications 
involving several organ systems. His flail 
chest required tracheostomy and assisted 
ventilation for four weeks. He developed a 
severe pneumonia which responded to spe­
cific antibiotic therapy. Because he had 
some degree of dysphagia, nasogastric tube 
feeding was started. In the third week he 
developed massive upper gastrointestinal 
bleeding which responded to blood transfu­
sion and antacid medications. When oral 
feedings were attempted we found he had 
paralysis of the muscles of deglutition and 
also bilateral vocal cord paresis. The naso­
gastric tube was reinserted and tube feed­
ings were reinstituted. Despite the tra­
cheostomy, gastroesophageal reflux and 
aspiration occurred owing to incompetence 
of the esophageal “ sphincter” and massive 
reflux. Because of these defects we created 
a pyloroplasty and a feeding gastrostomy. 
By the tenth week he had partial recovery 
of swallowing as his vocal cord function im­
proved. There was progressive improvement 
in his swallowing and phonation. At 12 
weeks the fractured femur was well healed 
and he sfarted to walk. Four months after 
the accident the patient was discharged and 
remains well more than two years after the 
accident.
Case 6.— M.W.. a 35-year-old woman, was 
admitted to the Ho^el Dieu Hospital, King­
ston, on October 10, 1971 after an auto­
mobile accident. Her multiple injuries in­
cluded lacerations of the scalp, fractured 
mandible, intra-abdominal bleeding, frac­
ture of the pedicles of the C2 vertebra with
Fig. 8. —Case 6. Marked mediastinal wide­
ning.
slight forward displacement of C2 on C3. 
Shortly after her admission she was taken 
to the operating room for a laparotomy and 
suturing of the lacerated liver.
In view of radiographic widening of the 
upper mediastinum (Fig. 8) emergency 
aortography was carried out through the 
right brachial artery (Fig. 9). This showed
Fig. 9.—Case 6. Right brachial arteriogram 
verifying the aortic tear and locating it in the 
area distal to the left subclavian artery.
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the classical fea tu res of a transection  of 
the aorta, d istal to  the le ft subclavian 
a rte ry . A t operation, using p a rtia l bypass, 
the aortic wall was found to be transected  
over five-sixths of its  circum ference w ith 
only a 1-cm. bridge of vessel wall le ft in tact. 
The aorta  w as divided, the edges were 
trim m ed and an end-to-end anastom osis was 
carried  out using a continuous su tu rin g  
technique.
A fte r closure, tracheostom y was done in 
view of the underlying pulm onary contusion 
and the facial in ju ries w ith  frac tu red  
mandible and swelling of the oropharynx 
and tongue.
The patien t required ventilator assistance 
for 10 days. There was progressive im prove­
ment in her general condition. One m onth 
la te r a Cloward procedure was done to 
stabilize the cervical spine. She has recov­
ered completely and has resumed her norm al 
activities.
Case 7.— L.P., a 13-year-old boy, was 
brought to the emergency ward of the  K ing­
ston General H ospital on January  21, 1972 
w ith multiple in ju ries sustained in an a u to ­
mobile accident. He had frac tu res  of both 
fem urs. A chest roentgenogram  showed a 
widened m ediastinum  and a small pneumo­
thorax on the r ig h t side. A righ t in tercostal 
chest tube was inserted. Em ergency trans- 
brachial aortography confirm ed the clinical 
suspicion of a traum atic  rup tu re  of the 
thoracic aorta. The tea r was beyond the 
origin of the left subclavian a rte ry . The 
pa tien t was taken directly to the operating  
room and th rough  a left thoracotom y the 
repair was carried  out under p artia l femoro- 
fem oral bypass. There was a large m edia­
stinal hematoma, and a transverse te a r  in 
the thoracic ao rta  involved practically the 
en tire circum ference. The narrow  bridge of 
aortic wall th a t rem ained was transected  
and an end-to-end anastom osis w as per­
formed. His recovery was uncomplicated. 
T reatm ent for the musculoskeletal in ju ries 
is be'ng  continued.
D iscussion
Although, sines the effective control 
of syphilis, m ost thoracic aneurysm s are  
a ttribu ted  to atherosclerosis, traum atic  
rup tu re  recently has become a sign ifi­
cant cause. In a series reported by 
Debakey et a l3 in 1958, traum a ac­
counted fo r only 15% w hereas in 1965
M cClenathan and B rettschneider4 re ­
ported th a t 28% of all thoracic  aneu­
rysm s seen from  1953 to  1964 were the 
resu lt of traum a. T raum atic  ru p tu re  of 
the thoracic a o rta  is common in h igh­
speed automobile accidents. In  his re ­
view of 72 autopsies in 1947, S trass- 
m ann5 noted th a t  70% of the deaths 
w ere caused by m otor vehicle accidents 
w hereas 86% of cases reported  by Mc­
C lenathan and B rettschneider4 in 1965 
were due to such accidents.
Pathogenesis and Mechanism of
Rupture
The m ajor m echanical fac to rs  leading 
to d isruption of the  ao rta  have been 
described as sudden deceleration in the 
horizontal or vertical plane w ith  devel­
opm ent of shearing and trac tio n  forces, 
com pression of th e  chest, and in tra ­
vascular bu rsting  tension. However, in ­
trav ascu la r bu rsting  tension is probably 
not sign ificant because, before ru p tu r ­
ing, a norm al ao rta  can w ithstand  in te r­
nal pressures of up to 2000 mm. Hg.6 
The m ajo r disruptive forces a re  those 
applied around the fixed and mobile seg­
m ents of the aortic  arch. The m edia­
stinal fixation of the  ascending ao rta , 
ao rtic  arch  and the  descending thoracic  
a o rta  varies. The tran sv erse  a rch  is 
relatively  fixed com pared w ith the as­
cending and descending aorta . The m ost 
vulnerable point is the  junction  of the 
a rch  and the  descending thoracic ao rta  
a t  the ao rtic  isthm us.2 T earing  a t  th is  
point is th ree  tim es as frequen t as in 
the  ascending and descending portions 
of th e  thoracic ao rta .2,6 The ligam entum  
arteriosum  no doubt plays a p a r t  in f ix ­
ing the isthm us and  thus in th e  in ­
creased incidence of tea rs  in th is  p a r ­
ticu la r location. In 13 of the 14 pa tien ts  
reported  by M cClenathan and B re tt­
schneider and in all seven of our pa­
tien ts  the rup tu re  took place a t  th is  
site.
Most aortic  tears a re  linear and in ­
volve p a rtia l o r complete transection  of 
the vesse l: others a re  spiral. This sup­
ports the  belief th a t shearing  from  sud­
den deceleration produces these lesions. 
Occasionally stellate in tim al and m edial
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tears are found, which may be the result 
of a compressive disruptive force.
Diagnosis
The surgeon must think constantly of 
aortic injury when he evaluates any 
blunt chest trauma. In 194 patients with 
chest injuries from car accidents Molnar 
and Pace1 found that one out of four 
had major injuries of intrathoracic or­
gans and one in 26 had traumatic rup­
ture of the thoracic aorta. Coexisting 
cerebral trauma, multiple fractures and 
internal injuries were frequent. More­
over, a patient may have a thoracic 
aortic tear with no gross evidence of ex­
ternal injury. Flail chest appears to be 
uncommon4 but three of our seven pa­
tients had “ stove-in” chests. Parmley 
et al,2 reviewed 275 autopsies of cases of 
non-penetrating injuries of the aorta 
and found that about 80% of these pa­
tients die before reaching a hospital. Of 
the rest, four of five live for one hour 
to several days before a fatal hemor­
rhage ensues; the fifth develops his 
aneurysm several months to years later. 
One of our patients had a sudden exsan­
guinating hemorrhage just as the diag- 
nois was made. Four remained stable 
for several hours. Two presented with 
an aneurysm three months and 10 years 
after the accident.
In the period immediately after trau­
ma the clinical manifestations of aortic 
injury may be obscured by the severity 
and extent of associated injuries. 
Craniocerebral trauma was the domi­
nant injury in two of our patients and 
the aortic lesion was not detected until 
much later. Fracture of the thoracic ver­
tebrae should alert the surgeon to the 
possibility of aortic injury. Any major 
chest trauma, however, should arouse 
his suspicion of a possible associated 
injury to the aorta. The diagnostic triad 
is (1) crushing chest trauma, (2) 
widening of the superior mediastinum 
and (3) hemothorax. Dyspnea, tachy­
cardia, hemoptysis, cyanosis, paraplegia 
and precordial pain have all been re­
ported. Extremely helpful signs are: an 
increase in the girth of the lower part of
the neck, a diminished or absent left 
radial pulse, a systolic murmur usually 
heard best in the left paravertebral area 
of the upper chest, and the development 
of upper limb hypertension with dimin­
ished or absent femoral pulses. These 
last two signs are considered to be diag­
nostic of aortic rupture.4 At times the 
systolic murmur is audible in the supra­
sternal notch.
Radiographs demonstrating a widened 
mediastinum must be interpreted as 
aortic rupture until this diagnosis is 
otherwise disproved. One must never be 
satisfied with an apparently normal ini­
tial film ; serial radiographs are man­
datory. Whenever there is widening of 
the mediastinum, emergency aorto­
graphy should be carried out. This pro­
cedure usually verifies the diagnosis and 
locates the site of the aortic tear thus 
dictating the appropriate surgical ap­
proach. In contrast to Katz and Briggs7 
who introduce the catheter via the 
femoral artery, we believe the aorto- 
gram should be done by the right bra­
chial route to avoid any catheter mani­
pulation at the site of the aortic tear. 
This will avoid any delay arising from 
difficulty in passing the catheter 
through the damaged segment. More­
over, this approach does not incur the 
risk of disrupting the adventitia which 
is usually all that contains the pul­
sating hematoma.
In the presence of severe blunt chest 
trauma, even where there are no radiol­
ogic signs of aortic rupture initially, 
one should do serial radiographs because 
traumatic aneurysms may show up 
days, months or even years after the 
original injury.8
Pathology
Parmley et al.* classified non-pene­
trating thoracic aortic injuries as fol­
lows: (1) intimal hemorrhage, (2) in- 
timal hemorrhage with laceration, (3) 
complete laceration of the aorta, (4) 
false aneurysm formation and (5) peri­
aortic hemorrhage. The findings in our 
seven patients may be classified as 
follows: complete transection (Cases 2 
and 4) ; partial laceration with false-
November 1972 RUPTURE OF THORACIC AORTA 357
aneurysm formation and calcification of 
the wall (Case 1) ; transection of one- 
half the aortic circumference with intact 
adventitia and periaortic hematoma 
(Case 5) ; four-fifths transection, dis­
section, hematoma and aneurysm forma­
tion (Case 3) ; and transection with an 
intact 1-cm. bridge connecting the tran­
sected edges, with false aneurysm for­
mation (Cases 6 and 7).
Treatment
The treatment of acute rupture of the 
thoracic aorta demands restoration of 
the continuity of the disrupted vessel, 
preferably by primary repair. Where 
this is not possible a prosthetic graft 
should be interposed.
While hemorrhage, infection and 
phrenic and recurrent laryngeal nerve 
palsy may complicate the repair of aor­
tic rupture, spinal cord damage, the 
most tragic of all, occurs in about 6% .2 
In 1951 Lam and Aram” replaced the 
thoracic aorta with a homograft and the 
patient developed a partial paralysis of 
the lower extremities. Ellis10 described a 
patient who had homograft replacement 
eight days after aortic injury and which 
required aortic clamping for 96 minutes; 
the patient developed motor and sensory 
loss in the lower extremities. The extent 
of neurologic damage appears to be de­
termined by the duration of aortic oc­
clusion, the extent of aortic resection, 
the number of intercostal arteries lig­
ated and the pattern of arterial supply 
of the spinal cord.11,12 Over the years 
surgeons have sought to protect the 
spinal cord and other viscera from ische­
mic damage by creating intraluminal 
or extraluminal shunts, by hypothermia 
and by various forms of partial extra­
corporeal circulation. This last is prob­
ably the method of choice and may be 
achieved in one of the following ways: 
(1) left subclavian-to-femoral artery 
bypass, (2) left atrium-to-femoral ar­
tery bypass or (3) femoral artery-to- 
femoral vein bypass. Whichever of these 
three methods he uses, the surgeon 
needs a thorough understanding of the 
normal anatomy and possible variation 
in the blood supply to the spinal cord.13
In their comprehensive review of the 
subject, Cole and Gutelius13 pointed out 
that left subclavian artery bypass is not 
free from neurologic complications and 
should not be used. Dumanian et al 
reported the use of deep hypothermia 
and total circulatory arrest. In two suc­
cessful cases this form of protection 
permitted 28 and 26 minutes of total 
circulatory arrest. We believe, however, 
that femoral vein-to-femoral artery by­
pass, using partial pump support with 
an oxygenator and filter in the system, 
is the safest and most versatile tech­
nique to provide distal flow during the 
repair. The pressure above the clamp is 
recorded from the right arm. Continu­
ous electroencephalographic recordings 
are made. By maintaining the right 
brachial pressure at or near normal 
levels— 100 to 120 mm. Hg—one can 
usually obtain flows of 1500 to 2000 ml./ 
min. through the pump system while 
the heart itself perfuses the brain ade­
quately. The pressure in the distal aorta 
under these circumstances is usually 
around 80 mm. Hg. Some advantages of 
this type of support are: (1) the femo­
ral vessel cannulas can be introduced 
under local anesthesia before the induc­
tion of general anesthesia; (2) the sur­
geon can initiate bypass and clamp the 
aorta any time after the chest is opened; 
(3) there is no tubing within the thora­
cic cavity so that the surgeon obtains 
maximal exposure of the involved area 
free from space-occupying tubes; (4) 
heparinization prevents vascular throm­
bosis and gives added protection to the 
spinal cord; (5) there is satisfactory 
perfusion to both the proximal aortic 
compartment and the distal vital or­
gans; (6) when required, the surgeon 
can easily institute total cardiopulmon­
ary bypass; (7) if necessary, the blood 
that has escaped into the thoracic cavity 
can be suctioned into and filtered in the 
pump system to restore circulatory 
blood volume rapidly.
Operative mortality during, and mor­
bidity after, surgical repair of acute rup­
ture depend largely upon the severity of 
associated injuries and their prompt 
diagnosis and treatment. With this type
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of approach in the emergency situation, 
treatment is successful in most patients.
With modern techniques of partial 
extracorporeal circulation and improved 
prosthetic grafts, elective resection of 
the descending thoracic aortic aneurysm 
has become common. Cooley resected 
aneurysms of the aortic isthmus in 60 
patients several months to years after 
trauma without any deaths.15 The un­
resolved question in operations for any 
'small chronic post-traumatic aneurysm 
that is asymptomatic and shows no 
signs of enlargement relates to the un­
predictability of spinal cord damage. 
The extent of resection, the number of 
intercostal arteries that must be inter­
rupted and the varying patterns of 
spinal cord blood supply are crucial fac­
tors in this unpredictability. For this 
reason some authorities recommend that 
patients with chronic aneurysm be close­
ly followed and the aneurysm be re­
sected only if there is clinical change, 
symptoms, or radiologic enlargement. 
While Cooley and DeBakey’6 estimated 
that patients with thoracic aneurysm 
had only six to eight months to live, 
their series was composed chiefly of 
syphilitic and atherosclerotic aneu­
rysms. Others give a much more favour­
able prognosis in asymptomatic trauma­
tic aneurysms. Of Steinberg’s patients17 
three were living at 21 to 27 years and 
one patient two years after trauma. One 
patient who had been asymptomatic for 
five years died after resection. Joyce 
et al.1* described patients thought to 
have traumatic aneurysm who survived 
at least nine years and commented on 
the favourable outlook. One of our pa­
tients is alive and well five years after 
his traumatic aneurysm was discovered 
and 15 years after the original injury.
Cough, dyspnea and pain in the back 
due to pressure on the vertebral column 
should warn the surgeon that the aneu­
rysm is expanding and provide an in­
dication for elective resection. Even 
though the aneurysm produces no symp­
toms, if periodic radiographs show an 
increase in size, surgical repair should 
be recommended. In the absence of these 
features and until we can delineate the
great radicular artery accurately and 
safely, some traumatic aneurysms must 
be managed conservatively by periodic 
radiographic follow-up.
S u m m a r y
In the period 1967 to 1972 seven pa­
tients sustained traumatic rupture of 
the thoracic aorta at the aortic isthmus 
following automobile accidents and pre­
sented at the Kingston General and 
Hotel Dieu Hospitals. One died before 
confirmation of the diagnosis. Four had 
emergency surgical repair. One had re­
section and insertion of a graft four 
months after the accident. Another pa­
tient who presented with a chronic, 
heavily calcified aneurysm is being man­
aged conservatively and is well 15 years 
after the initial trauma. There was no 
surgical mortality.
Since only one out of every 20 pa­
tients who sustain traumatic rupture of 
the thoracic aorta survives for longer 
than three weeks, surgical correction 
with primary repair or prosthetic graft­
ing must be carried out when the diag­
nosis is made early. The surgeon must 
think of aortic injury in every patient 
with multiple trauma and blunt injury 
to the chest. A diminished or absent left 
radial pulse and a systolic murmur in 
the left paravertebral area of the chest 
are extremely helpful signs in making 
the diagnosis. Widening of the media­
stinum in the chest radiograph makes 
aortography mandatory. The aortogram 
verifies the diagnosis and locates the 
site of the tear. In selected asymptoma­
tic small aneurysms detected months or 
years after injury, conservative man­
agement by regular follow-up is consi­
dered justifiable.
A ddendum
Since the submission of this paper for 
publication a 37-year-old man was found to 
have a “mediastinal mass” on a routine chest 
radiograph. Investigation revealed this to be 
a typical traumatic thoracic aortic aneu­
rysm distal to the left subclavian artery. 
It was believed to have been sustained in a 
motor vehicle accident in 1964, at which 
time the patient suffered head injury with
November 1972 RUPTURE OF THORACIC AORTA 359
unconsciousness, chest injury, prolonged 
sternal pain and fractured ribs, and a frac­
tured femur. At the time o f its discovery 
the aneurysm was entirely asymptomatic. 
It was elected to examine the patient at 
intervals according to the principles out­
lined in this report.
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R esu m e
Au cours de la periode de cinq ans de 1967 
a 1972, sept malades ayant subi une runture 
traumatique de l’aorte thoracique au niveau 
de l’isthme aortique. au cours d’accidents de 
la route, ont ete admis dans deux hopitaux 
de Kingston, Ontario (le Kingston General et 
l’Hotel-Dieu). Un de ces accidentes est mort 
avant aue le diagnostic ait ete confirme. Qua- 
tre patients furent operes d’urgence. Un autre 
subit une resection et une greffe quatre niois 
apres Taccident. Un autre malade, oui presen- 
tait en outre un anevrysme chronique forte- 
ment calcifie, est traite par des moyens con- 
servateurs et se porte bmn 15 ans apres le 
traumatisme original. On n’a enregistre aucune 
mortality operatoire.
Etant donne que, parmi les malades qui sont 
victimes d’une rupture traumatique de l’aorte, 
un seul sur 20 survit plus de trois samaines, 
l’operation, refection primaire ou greffe d’une 
prothese, s’impose quand le diagnostic a ete 
pose precocement. Le chirurgien devra songer 
a une lesion aortique chez tout patient ayant 
subi de multiples trauma tismes et une blessure 
contondante du thorax. Un nouls radial gauche 
faible ou absent ou un souffle systolique dans 
la region paravertebrale gauche du thorax sont 
des signes qui facilitent grandement le diag­
nostic. Un elargissement du mediastin sur la 
radiographie thoracique rend imperieuse une 
aortographie. Cet examen permet de verifier 
le diagnostic et de localise!' le siege de la de- 
chirure. Dans un certain nombre de cas choisis 
de petits anevrysmes asymptomatiques qui ne 
sont deceles que des mois ou des annees apres 
Taccident. on considere comme justifie un trai- 
tement conservateur avec examans de controle 
frequents.
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ELECTROLYTES OF GASTRIC JUICE COLLECTED FROM TOTALLY 
ISOLATED CANINE EX VIVO STOMACHS*
K. KOW ALEW SKI, Ph.D., M.D. and R. SCHARF, M.D.,f Edmonton, Alta.
M o st  physiologists agree that the con­
centration of H+ in the primary sec­
retion of parietal cells is higher than 
that of the gastric content collected by 
usual methods.1,2 The mechanism un­
derlying this phenomenon is not yet 
known. Numerous hypotheses have been 
proposed to explain not only the me­
chanism of H+ production but also the 
variations in the ionic composition of 
gastric juice associated with the 
changes in gastric acidity. The subject 
of electrolytes of mammalian gastric 
juice was reviewed recently by Hunt 
and Wan,2 who discussed various hypo­
theses in detail and examined them 
critically. The majority of these hypo­
theses agree that the variations of H + 
concentration and osmolarity of the gas­
tric juice depend mainly on secondary 
factors, e.g. buffering by non-parietal 
gastric secretion, back diffusion of ions 
operating after the elaboration by the 
parietal cells of a theoretical “ primary” 
acid gastric juice of variously described 
composition.2,3
The most important difference be­
tween these hypotheses is the inter­
pretation of the relationship between 
Na+, H+ and Cl and quantitative char­
acterization of this relationship. Vari­
ous conditions under which the gastric 
juice is collected by the students of gas­
tric electrolytes may be, in part, respon­
sible for some differences in ionic meas­
urements. Human gastric secretion may 
be contaminated (saliva, duodenal 
ju ice ); experimental canine pouches 
may not represent total mucosa (Hei- 
denhain pouches and fundic isolated 
segments) and are deprived of the an­
trum, which is an important producer 
of alkaline component.4
*From the Surgical-Medical Research Institute 
and Department of Surgery, The University 
of Alberta, Edmonton, Alta.
(■Fellow in Experimental Surgery, supported 
by the Edmonton Civic Employees Association. 
Present address: Institute of Hematology,
Warsaw, Poland.
For the last seven years we have been 
using a preparation that permits the 
collection of pure gastric juice from 
a total ex vivo canine stomach. Such 
an isolated organ can be perfused with 
homologous or autologous blood for at 
least 24 hours, and stimulated gastric 
secretion can be obtained during this 
perfusion period.511
We previously reported mainly on H ! 
and pepsin secretion of ex vivo canine 
stomachs. The purpose of the present 
study was to investigate the ionic com­
position of pure gastric secretion col­
lected from ex vivo canine stomachs and 
to analyze quantitatively the relation­
ship between the major electrolytes in 
this secretion.
M e t h o d
Perfusion System
The perfusion chamber and the cir­
cuitry of perfusion were previously de­
scribed in detail.9' 12 Only the most 
pertinent information will, therefore, be 
repeated (Fig. 1). The perfusion cham­
ber housing an ex vivo organ assures 
a precise control of temperature, humid­
ity and pressure. Blood is delivered to 
the stomach with the help of an oc­
clusive roller pump (Sarns low-flow per­
fusion pump, No. 5M-6050, Travenol 
Laboratories Ltd., Alliston, Ont.). Ar­
terial blood-flow rate can be arbitrarily 
varied by adjusting the pump speed 
selector, or it can be controlled automa­
tically to deliver a constant, selected, ar­
terial perfusion pressure. The latter 
facility utilizes a feedback channel re­
sponding to the galvanometer voltage 
from an arterial pressure channel on a 
recorder (Offner Type R biomedical 
recorder, Beckman Instruments, Inc., 
Palo Alto, Calif.). The height-adjust­
able reservoir receives venous outflow 
blood from the stomach. A second roller 
pump (Sarns modular pump No. 5M- 
6002) returns blood to the supporting
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STIMULANT INFUSION PUMP
Fig. 1.—Circuitry for ex vivo perfusion of isolated canine stomach. A  supporting dog or 
a bubble oxygenator is supplying perfusion blood with oxygen.
animal or an oxygenator, at a rate that 
is automatically controlled by photoelec­
tric sensing of the blood level in a 
venous reservoir.12 A small amount of 
blood escaping from the preparation is 
delivered, by a third pump, to the 
venous circuit. Priming volume of the 
entire flow circuit is 200 ml. Oxygena­
tion of perfusion blood takes place in 
a supporting dog or in an oxygenator 
(Fig. 1). The supporting dog, previous­
ly gastrectomized and under sodium 
pentobarbital anesthesia, breathes spon­
taneously during the perfusion. How­
ever, intermittent positive-pressure hy­
perventilation is carried out and oxy­
gen insufflation is provided if arterial 
pOa is less than 60 mm. Hg. For extra­
corporeal perfusion we use a bubble 
oxygenator (Mini-prime 2LF, total body 
perfusion oxygenator, Travenol Labora­
tories, Inc., Morton Grove, 111.), which 
is indicated in Fig. 1. This oxygenator 
receives pure oxygen or an appropriate 
mixture of oxygen and carbon dioxide 
delivered under manometric control.
Isolation of the Stomach
The stomach of a dog, fasted for 18 
hours, is dissected carefully, avoiding 
any handling of the organ and working 
essentially on the vascular system. Ma­
jor steps of dissection are: (a) splenec­
tomy and subtotal omentectomy, (b) 
ligation and division of the infraceliac 
aorta, (c) division of the thoracic aorta,
(d) division of the retroperitoneal at­
tachments of the paraceliac aorta, and
(e) division of the distal portal vein. 
The dissected organ is weighed and im­
mediately placed in the chamber so as to 
rest on the ventral wall. The transfer 
period, equivalent to the complete arrest 
of circulation, lasts from four to nine 
minutes.
Perfusion
Stomach vasculature is connected 
with the perfusion circuit by the prece­
liac segment of the aorta and the distal 
portal vein, using appropriate cannulas. 
The outlet of the intragastric cannula,
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secured by a ligature around the duo­
denal sphincter, is placed outside the 
chamber. The chamber is sealed and in­
termittent respiratory-rate pressures of 
+ 8/+3 mm. Hg are produced using res­
piratory pumps (Fig. 1). Venous reser­
voir height and pump volumes are ad­
justed to produce a pressure of +8 /+9 
mm. Hg in the portal vein. During the 
first 15 to 20 minutes of perfusion the 
stomach, which was not washed after 
dissection, is permitted to drain spon­
taneously. Most of the preformed se­
cretion is evacuated by this method. 
When circulation in the system is well 
stabilized and the stomach is emptied, 
we begin intra-arterial infusion of his­
tamine dihydrochloride, 150 /xg./hr. The 
body weights of donors of ex vivo 
stomachs varied from 20 to 24 kg. Ini­
tial weights of isolated stomachs ranged 
from 295 to 386 g.
Measurements
Arterial and portal venous pressure 
and arterial flow rate were constantly 
monitored during the perfusion (Zepeda 
EPD-2RD, Zepeda Instruments, Seattle, 
Wash.). Arterial and venous pCL, pCCL 
and pH were measured every 30 min­
utes. Stomach oxygen consumption was 
calculated, using arterial flow rate and 
arteriovenous oxygen content differ­
ences. Gastric juice was collected con­
tinuously in 30-minute samples. Gastric 
acidity was determined with an automa­
tic titrator (Radiometer Model TTT1 
titrator). This method permits the re­
cording of the total titratable (to pH 
7.0) H+, representing HC1 that is com­
pletely dissociated, and that buffered 
by the presence of other substances. The 
concentrations of Na+ and K+ were de­
termined using a flame photometer 
(I.L. Model 143). Chloride was meas­
ured with a chloridometer (Buchler- 
Cotlove model) and calcium was deter­
mined photometrically.13
The results of biochemical studies of 
gastric juice ions were processed with 
the help of a computer. The regression 
analyses of paired data for H+, Na+ 
and Cl“ were carried out using the tech­
niques described by Smillie.14 The pro-
TABLE I.— Secretion of Ex  Vivo Canine 
Stomachs Stimulated by Constant Intra 
arterial Infusion of H istamine (150 iaG./hr.). 
Duration of Perfusion A veraged Six Hours 
(4.0-8.0). Samples T aken Every 30 M inutes. 
M ean and R anges (in Brackets)
Perfused with blood circul­
ating through
Components
Supporting
dog
Bubble
oxygenator
No. of stomachs 25 8
No. of 30-min. samples 268 115
Gastric juice
Vol. ml./30 min. 37 37
(12-98) (7-72)
HC1 mEq./30 min. 4.8 0
H+ mEq./l
(1.2-7.5)
97 0
Na+ mEq./l.
(4-1.67)
56 146
(6-139) (128-165)
K+ mEq./l. 6.6 6.1
(2.3-12.3) (4.0-11.0)
CL mEq./l. 154 120
(110-181) (116-146)
Perfusion blood
Na+ mEq./l. 147 150
(140-149) (141-174)
K+ mEq./l. 3.5 3.4
(3.2-3.8) (3.0-4.1)
CL mEq./l. 110 116
(107-126) (100-135)
Hematocrit (%) 40 34
(38-43) (28-52)
Arterial pH 7.30 7.30
(7.15-7.49) (7.15-7.54)
Arterial blood 110 108
flow /ml. /min. /stomach (60-150) (70-170)
0 2 consumption 2.21 1.20
ml. /min. /stomach (0.70-6.00) (0.50-1.98)
gram SR was run on the University of 
Alberta IBM 360/67 computer. For cal­
culations of significance Student’s t test 
was used.
R esu l ts
Table I summarizes the results ob­
tained in two series of ex vivo stomachs. 
It can be noted that all stomachs sup­
ported by a living dog-oxygenator pro­
duced secretions containing H+. All 
stomachs oxygenated in vitro (bubble 
oxygenator) produced alkaline juice. No 
marked differences were noted between 
the composition of blood in the two sys­
tems. Oxygen consumption was, how­
ever, higher in H +-producing stomachs 
than in stomachs which secreted only 
alkaline juice.
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Fig. 2.—Relationship between the concentra­
tions of H + and Cl- . Regression line is given 
by the equation: [C l- ] =  137.8 +  0.1775 x 
[H + ] mEq./l. The standard error o f the slope 
is 0.1266. The correlation coefficient =  0.652, 
t is 14.0 and N =  268.
Fig. 2 contains the paired concentra­
tions of H+ and Cl“ . The line represents 
the least-squares best fit for a straight 
line. The equation of the line is [Cl~] = 
137.8 + 0.1775 x [H+] mEq./l. The 
standard error of the slope was 0.1266, 
the correlation coefficient was 0.652, t 
was 14.0 and N = 268. The straight line 
gives a reasonable fit to the data, and 
any curved line would evidently not 
yield a smaller sum of squares of devia­
tions. While the standard error of the 
slope is considerable, there is clearly a
[H+] mEq./L
Fig. 3.—Relationship between the concentra­
tions o f H + and Na + . Regression line is given 
by the equation: [Na + ] =  127.5 — 0.7363 x 
[H + ] mEq./l. The correlation coefficient =  
-0.962, t is 57.8 and N =  268.
relationship and the value of t is very 
large. The probability that the observed 
slope is not significant is thus exceed­
ingly small (P < .001).
Fig. 3 shows the relationship between 
the concentrations of Na+ and H +. The 
equation of the linear regression line is 
[Na+] =  127.5 -  0.7363 x [H+] mEq./l. 
The correlation coefficient was -0.962, 
t was 14.0 and N = 268. The question 
whether a curved line of any sort would 
give a closer fit to the data was con­
sidered. Unless the data were selected,
TABLE I I —Comparison of the Calculated Primary Concentrations of the Non-parietal Compo­
nent (Makhlouf, M cManus and Card) and the Data Obtained Following Gastric Intra-arterial 
Infusion (Altamirano) or Topical Application of Acetylcholine (Hollander) With our Results 
in Ex Vivo Canine Stomachs, Perfused W ith Blood Circulating Through a Bubble Oxygenator.
Mean Values
Makhlouf,
McManus and Card16 Altamirano 34 Hollander 17 Our results in ex
Component in man in dog* in dogt vivo canine stomacht
Na+....................  136.7 137.8 133.0 146 0
K+......................  6.4 3.5 4.4 6.1
Cl- .....................  117.0 116.0 120.0 120.0
‘ Isolated segments of canine gastric fundi, in vivo. 
tHeidenhain pouch, 
t Compare with Table I.
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TABLE I I I — Comparison of Electrolyte Concentration in Gastric M ucinous Secretion (H ol­
lander) and the Concentration of Electrolytes in the Secretion of Ex  V ivo Canine Stomachs 
W ith Electrolytes of D og Plasma. N umber of 30-M inute Samples was 115. M eans and R anges (in
Brackets)
Component
Hollander17 * Ex vivo stomachsl
Mucinous secretions Dog plasma Gastric juice Perfusion blood (plasma)
Na+ 133.0 (114 - 148) (135 - 169) 146.0 (128 - 165) 150.0 (141 - 174)
K + 4.4 (2.5 - 6.9) (3.7 - 6.2) 6.1 ( 4.0 - 11.0) 3.4 (3 . 0 - 4 .1 )
Ca++ 3.7 (2.4 - 5.0) (4.5 - 6.1) 4.0 ( 2.7 - 6.0) 5.0 ( 5.6 - 6.4)
CD 120.0 (96 - 144) (99 - 136) 120.0 (116 - 146) 116.0 (100 - 135)
HCOs 13.0 (6.5 - 29.8) (18 - 24) 14.0 ( 8.0 • 24.0) 17.5 ( 14 - 26)
•Heidenhain pouches stimulated by acetylcholine.
tTotal canine ex vivo stomach, stimulated by histamine and perfused with autologous or homologous 
blood circulating through a bubble oxygenator.
a curved line would not, in our opinion, 
significantly lower the sum of the 
squares of the deviations.
In Tables II and III we compared the 
results obtained by the analysis of alka­
line gastric juice in our study with the 
results reported by other authors who 
investigated non-parietal or alkaline 
component of gastric secretion. It may 
be noted from these tables that the over­
all composition of alkaline secretion ap­
proaches the ionic composition of blood 
serum or extracellular fluid.
D is c u s s io n
The ex vivo preparation described 
above differs considerably from the 
preparations used by previous students 
of gastric electrolytes. The ex vivo 
stomach produces pure juice, which is 
not contaminated by saliva or duodenal 
content. The ex vivo stomach also in­
cludes the antrum, a rich source of non- 
parietal secretion, and in this regard 
differs from fundic pouches used for 
the study of gastric juice electrolytes in 
experimental animals.
Major Ions of Gastric Juice
Every ex vivo stomach, perfused with 
homologous blood of a living supporting 
dog and stimulated with histamine, pro­
duced a secretion containing H +. The 
range of acidities obtained in 268 30- 
minutes samples varied from 4 to 167 
mEq./l. The highest concentration of 
H+ found in this series was therefore 
quite similar to the value of 160 mEq./l.
reported as the maximal concentration 
of H+ for in vivo stomachs.2 The con­
centration of CD, the major anion of 
gastric juice, varied from 110 to 181 
mEq./l., the maximal value obtained 
being 181 mEq./l. This again compares 
well with the maximal value of 179 
mEq./l. found in histamine-stimulated 
human gastric juice.15 Also, the ranges 
of K+ reported for human gastric 
juice16 and dogs with fundic pouches17 
are similar to the range found in our 
study.
Finally, the values for Na+ in this 
study varied from 6 to 139 mEq./l. They 
consistently declined when H+ secretion 
was stimulated and they increased at 
low acidities. In human subjects the 
concentration of Na+ also reached its 
highest values at the same time as acid­
ity approached neutrality.16
Relationship Betiveen Concentration
of H+ and Cl~
It was reported previously that the 
relation between concentration of CD 
and ED may be expressed as rectilinear. 
Such a regression line was obtained by 
Hollander18 and Gray and Bucher19 who 
analyzed pooled samples of canine juice. 
According to Hunt and Wan2 the weak­
ness of the rectilinearity concept2 is the 
small range of acidities studied. These 
were, respectively, 100 to 160 mEq./l.18 
and 90 to 140 mEq./l.19 in the reports 
quoted. Despite this narrow range of 
acidities, a rectilinear regression line 
was established by extrapolation to 170 
mEq./l. of CD and to zero concentration
*
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of acid.2,18 This method of extrapolation 
may be open to criticism.2
The concentration of acid varies, usu­
ally between 0 and 150 mEq./l.2 The con­
centration of chloride increases linearly 
with the concentration of acid but only 
over a limited range.2, 18, 20-22 Some diffi­
culties occur when the results are 
examined over the range 0 to 170 mEq./ 
1.; in these areas, according to Hunt 
and Wan,2 the relation is expressed best 
as curvilinear.
In our study the range of acidities is 
extremely large (4 to 167 mEq./l.) and, 
in this respect, we would be safe from 
Hunt and Wan’s criticism.2 Preparing 
the regression line for H+ and CP, we 
did not need to extrapolate to zero or to 
maximal concentrations. A straight re­
gression line fitted the data well, par­
ticularly the central part of the graph. 
It is possible also to express the extrem­
ities of this line as parabolic. Riddell, 
Strong and Cameron,23 discussing the 
numerical estimate of Na+ and H+ rela­
tionship, found that the extremities of 
the regression line were best expressed 
as parabolic. They concluded, however, 
that this was unnecessary refinement 
which might lead to fallacious conclu­
sions. They accepted the straight line 
as most realistic. They noted that, at the 
extremities of the line, some observa­
tions were “ erratic” . “ The inequality of 
errors in observation of the small vari­
able could make the regression line 
curved at its ends.”23 We accept the 
comment of these authors23 as a guide­
line in evaluation of our regression 
lines, and feel that in the absence of 
compelling evidence the simplest inter­
pretation is the most satisfactory.
Relationship Between Concentration
of H+ and Na+
Hollander18, 24, 25 and Gray and 
Bucher19 concluded that there was a rec­
tilinear relationship between concentra­
tion of H+ and Na+. Riddell, Strong and 
Cameron,23 after the above-mentioned 
comment, also preferred the straight re­
gression lines to other estimates of the 
association between the concentrations
of these two ions. Milton, Skyring and 
George26 found, in cats, the concentra­
tion of Na+ and H+ ranging from 0 to 
120 mEq./l.: the plot of concentrations 
of these two ions was rectilinear. Some 
authors obtained a rectilinear relation, 
in human gastric juice, between H+ and 
Na+ but only at the limited range of 
acidities.20, ” •27-29
Hirschowitz15 made repeated studies 
in one human subject and found that 
linear correlation between H + and Na + 
was “good” , but there was also “a cur­
vilinear trend” . Such a trend and its 
significance were discussed by Riddell, 
Strong and Cameron23 quoted above. It 
should be mentioned that some of the 
important studies predicting a cur­
vilinear relation between concentration 
of H+ and Na+ are based on the evalua­
tion of reabsorption of HC1 instilled 
into the stomachs of animals.30-32 Such a 
method cannot be compared with our 
collection of pure gastric juice in totally 
isolated stomachs. Two important stu­
dies of histamine-stimulated human gas­
tric secretion, one by Makhlouf, Mc­
Manus and Card16 and another by Nord- 
gren,33 support the concept of a rec­
tilinear relation between the concentra­
tions of H+ and Na+ in gastric juice. It 
appears therefore that our results re­
garding the relationship between con­
centrations of H + and Na+ in the pure 
canine gastric juice, collected from ex 
vivo stomachs, agree with findings in 
in vivo human and animal gastric secre­
tion.
Sum of the Cations and Anions of
Gastric Juice
An important relationship between 
Cl” and the sum of H+, Na+ and K + of 
gastric juice deserves a short discus­
sion. This relationship can be expressed 
by an equation stating that total Cl" 
approaches the sum of Na+ + K + + H + 
over a certain range of Cl“ values. This 
indicates that Cl“, for all practical pur­
poses, is the only anion in gastric juice.15 
This equation is evidently a simplified 
one.17 We compared the sums of H +, K + 
and Na+ with Cl" using 176 samples of
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30-minute secretions. We obtained for 
the sum of the cations the value 164.4 
±  14.5 mEq./l., and for Cl" the value 
160.4 ±  13.0 mEq./l. The ranges for 
H +, K+, Na+ were respectively: 7 to 
167; 2.9 to 12.1; and 4 to 139; and for 
Cl" the range was 126 to 181. Close 
similarity between the sum of cations 
and the value for Cl" seems to indicate 
that the above-mentioned equation was 
verified in the present experiment.
Alkaline Gastric Juice
In none of the ex vivo stomachs per­
fused with autologous or homologous 
blood circulating through a bubble oxy­
genator was gastric juice H+ detected 
by the method used. The cause of this 
“ functional block” of parietal cells is 
not known. That this is not a permanent 
block, due to damage, but a transitory 
arrest of function was proved in the 
following experiment, which will be 
reported separately: when a supporting 
dog is connected to the perfusion system 
(Fig. 1) and the bubble oxygenator re­
moved, ex vivo stomachs, previously 
resting as far as H* secretion is con­
cerned, start to produce acid. In the 
presence of the bubble oxygenator, only 
alkaline juice is produced.
Alkaline gastric juice was sometimes 
recovered from patients with various 
gastrointestinal disorders. Besides this 
indirect evidence for non-parietal sec­
retion,2 some experiments show directly 
the production of non-parietal, alkaline 
juice.2’ 15,” ■2I> “ • 34. When acetylcholine 
was given intra-arterially,34 alkaline 
juice was produced by the fundic 
pouches of dogs. Similar results were 
obtained by others.”  Altamirano34 found 
that concentrations of ions of the 
“ pure” postacetylcholine alkaline secre­
tion were characteristic of an ultrafil­
trate of plasma to which has been added 
the secretion of the mucous cells. The 
final fluid was iso-osmotic with plasma. 
Hollander”  introduced acetylcholine 
topically into Heidenhain pouches and 
obtained the juice free of cells and of 
H+. He states that the mucinous secre­
tions so obtained had an electrolyte pat­
tern essentially the same as that for dog 
plasma or interstitial fluid.
We compared the previous data on 
non-parietal secretions16, ” •34 with those 
in our experiment (Tables II and III). 
It may be observed that alkaline secre­
tions from the ex vivo stomach have a 
composition approaching that of blood 
plasma. Higher gastric juice sodium in 
our series may be due to the presence of 
the antrum, absent in the preparations 
of Altamirano and Hollander. Of partic­
ular interest is the similarity between 
Cl" in all four series (Table II). Alka­
line juice obtained in our experiment 
appears comparable, in regard to the 
composition of electrolytes, to non- 
parietal juice found in human subjects 
and dogs studied in in vivo conditions.
In summary, then, a linear relation­
ship was shown to exist between the 
concentrations of Na+ and H+ and be­
tween the concentration of Cl" and HC 
We were able to analyze a large popula­
tion of 30-minute samples (268) of gas­
tric juice. The range of acidity in this 
series was very large and no extra­
polation to extreme values of concentra­
tion of H+ or Cl" was necessary. In this 
way a criticism of “ too-narrow range” 
forwarded by Hunt and Wan,2 and dis­
cussed above, could be easily avoided. 
Regarding the composition of “non- 
parietal component” , which was found 
in alkaline juice of oxygenator-sup­
ported stomach, this component was 
shown to be nearly identical with plas­
ma (and interstitial fluid).
Our present experiments show that in 
a pure gastric secretion, obtained from 
a totally isolated canine stomach, ionic 
composition is generally similar to that 
observed in in vivo conditions in man 
and animals.
Sum mary
The perfusion-oxygenation of totally 
isolated canine ex vivo stomachs was 
studied using two systems: System I 
contained a living “ supporting dog” 
which served as oxygenator-dialyzer of 
circulating homologous blood. System II 
contained a bubble oxygenator. All 
stomachs perfused with System I and
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stimulated intra-arterially with hista­
mine secreted gastric juice containing 
H ‘ . However, the histamine-stimulated 
stomachs perfused under System II pro­
duced only alkaline juice. Regression 
lines were prepared by computer for the 
concentration, in gastric juice, of H+ 
versus Cl~ and for the concentration of 
H+ versus Na+. In both instances the 
relationship was found to be rectilinear. 
Analysis of alkaline juice obtained from 
stomach perfused with “System II” de­
monstrated that the ionic composition 
of this non-parietal secretion ap­
proached the ionic composition of blood 
serum of perfusion blood. Our results 
were compared to those of various 
authors who studied ionic composition 
and exchange in the stomachs of human 
subjects and experimental animals.
We are grateful to the following persons 
for their assistance: Mr. A. Kolodej and Mr. 
R. Orchard for their valuable assistance with 
the surgery and perfusion experiments; to 
Mrs. M. McCubbin and Mr. T. Pachkowski who 
performed biochemical tests and made statis­
tical evaluations of the results, and to Dr. 
J. C. Russell who prepared the analysis of 
regression lines from the computer data.
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R esu m e
Les auteurs ont etudie la perfusion et l’oxy- 
genation d’estomacs canins ex vivo totalement 
isoles. Ils ont, a cet effet, utilise deux syste- 
mes: le systeme I comportait un “ chien de sou- 
tien” vivant qui servait d’oxygenateur et de 
dialyseur de sang homologue circulant. Le 
systeme II comportait un oxygenateur a bul- 
les. Tous les estomacs perfuses par le systeme 
I et stimules par injection intra-arterielle 
d’histamine ont secrete un sue gastrique con- 
tenant H + , tandis que les estomacs stimules 
par l’histamine et perfuses dans le systeme II 
n’ont secrete qu’un sue alcalin. Les auteurs ont 
prepare par ordinateur les courbes donnant la 
concentration dans le sue gastrique, de H + 
par rapport a CL~ et la concentration entre 
H+ et Na+. Dans les deux cas, le rapport ob- 
tenu etait une ligne droite. L’analyse du sue 
alcalin secrete dans les estomacs perfuses par 
le systeme II a mis en lumiere que la compo­
sition ionique de cette secretion non parietale 
etait voisine de celle du serum sanguin du 
sang transfuse. Nous avons compare nos resul- 
tats a ceux d’autres auteurs qui avaient etudie 
la composition et les echanges ioniques dans 
des estomacs humains et des animaux d’expe- 
rience.
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CANCER OF THE COLON IN PATIENTS WITH ULCERATIVE 
COLITIS SINCE CHILDHOOD*
GHISLAIN J. DEVROEDE, M.D.,f MALCOM B. DOCKERTY, M.D., 
WILLIAM G. SAUER, M.D., RAYMOND J. JACKMAN, M.D. and 
GUNNAR B. STICKLER, M.D., Rochester, Minn., U.S.A.
T h e  association of cancer of the large 
intestine and ulcerative colitis is well 
known.1'17 In a previous study we showed 
that cancer of the large intestine fre­
quently develops in patients who have 
had ulcerative colitis since childhood.18 
We now present data on the prognosis 
of such cancer and describe the charac­
teristics of this type of lesion.
M a t e r ia l s  a n d  M e t h o d s
The series comprised 77 patients with 
childhood ulcerative colitis (before the 
age of 14 years) who later developed 
carcinoma of the large intestine; in­
clusion in the series was dependent on 
the availability of at least one histologic 
section for review. The patients were 
drawn from two different groups: (1) 
Follow-up of 396 children with ulcera­
tive colitis18 who were seen at the Mayo 
Clinic, Rochester, between December 1, 
1919 and December 1, 1965, provided 
data on 52 patients who developed car­
cinoma of the large intestine before 
December 1, 1966; histologic material 
was obtained on only 40 of these pa­
tients. (2) From December 1, 1919 to 
December 1, 1966, 37 adults were seen 
who had cancer as a complication of 
persistent ulcerative colitis. As ascer­
tained from the history18 and other 
evidence, the colitis had begun before 
the age of 14 years. All of these 37 pa­
tients had rectal disease, none had skip 
areas in the large intestine and none 
had regional enteritis.
From the records of the first group 
of 40 patients followed at the Mayo 
Clinic from childhood, we determined 
the severity of their disease between the 
time of diagnosis of ulcerative colitis 
and the time of the subsequent diag-
‘ From the Mayo Clinic and Mayo Foundation, 
Rochester, Minn., U.S.A.
fCentre Hospitalier Universitaire, Sherbrooke, 
Que.
TABLE I.— Criteria for Classification of 
Course of Colitis from Follow-up of 40 Pa­
tients W ith Ulcerative Colitis in W hom 
Cancer Developed
Course Activity Complication
Mild Regular None
Moderate Confinement <1 
mo. at home
Severe Confinement >1 
mo. at home or <1 
mo. in hospital
Anemia, weight loss 
or growth failure, 
arthritic or ocular 
manifestations, 
erythema nodosum
Anemia (>  10 
transfusions/yr.), 
recurrent phlebitis, 
pyoderma gangre-
nosis of carcinoma (Table I). The path­
ological specimens were studied by one 
of us (M.B.D.) who at the time was not 
aware of the clinical data. The chi- 
square test was used in the statistical 
analyses. Survival curves were calcul­
ated by a standard actuarial method.
R e s u l t s  
Clinical Data
The ulcerative colitis was mild in 22 
of the 40 patients followed from child­
hood to the development of cancer. 
Eleven of the 77 patients had had com­
plete remissions of one to 19 years be­
fore carcinoma of the large intestine 
developed in the presence of the quies­
cent ulcerative colitis.
TABLE II.—Age Distribution at the T ime of 
D iagnosis of Cancer
Age (years) No. of patients
10-19.......................................... 7
20-29.......................................... 40
30-39.......................................... 27
40-49.......................................... 2
50-59.......................................... 1
Total.......................................... 77
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TABLE III.— N ew M anifestations W hen Can­
cer D eveloped in 63 Patients
TABLE V.— H istologic Classification of 
C ancers
New manifestation No. of patients Histologic type Cancers
Subjective:
Pain..........................................  28
Fatigue
Present............................................ 21
Absent.................................  29
No data.........................................  13
Appetite
Loss......................................  20
Normal................................  28
No data..........................................  15
Constipation...........................  5
Objective:
Palpable abdominal mass. . .  12
Obstruction.............................  9
Weight
Loss......................................  26
Unchanged.....................................  13
No data...............................  24
Anemia (Hb. g./lOO ml.)
Under 10........................................  16
Over 10........................................... 23
No data..........................................  24
The youngest patient was 10 years 
old and the oldest was 52 years old; 
96% were less than 40 years old when 
cancer developed (Table II).
Eleven patients had no new com­
plaints when the cancer developed. In 
63 others on whom data were available, 
the most common warning manifesta­
tions were pain and loss of weight 
(Table III). Cancer was suspected be­
fore operation in only 35 of the 75 
patients (47% ) for whom data were 
available. The diagnosis was made at 
autopsy in four (Table IV).
TABLE IV.—M ethod of D iagnosis of Cancer
Adenocarcinoma.....................................  44
Small cell carcinoma.............................  4
Mucus-producing carcinoma...............  24
Scirrhous carcinoma............................  20
Adenoacanthoma.................................... 3
Basaloid carcinoma................................ 1
Giant cell carcinoma.............................  1
Carcinoid.................................................. 2
Total.........................................................  99
Pathological Findings
Twenty-one of 67 patients (31%) on 
whom adequate data were available had 
multiple invasive cancers. Besides an 
invasive growth, 12 other patients had 
multiple sites of cancer in situ. A total 
of 99 invasive cancers developed in the 
entire group.
The histologic features of the cancers 
varied considerably (Table V, Figs. 1 
and 2). The lesions were classified by 
grade and site of occurrence (Table 
VI). About 55% of all cancers were 
either grade 3 or grade 4 (Broders’ ). 
Test of homogeneity revealed that can­
cers were scattered uniformly through­
out the large intestine; the different 
grades of tumours showed no predilec­
tion for site (P >  0.05). Of 80 cancers 
for which information was available, 
50 (63%) were associated with nodal 
metastases. In 43 of 64 patients (67%) 
on whom data could be gathered, distant 
metastases had already developed when 
the diagnosis was made.
Patients
Method of diagnosis No. %
Proctoscopic examination. . .  15 20
Roentgenologic examination 20 27
Surgical exploration............... 35 47
Autopsy...................................  4 5
Biopsy*....................................  1 1
Total...................... •................  75t 100
*Cancer of colon not suspected on biopsy of neck 
nodule.
tData not available on two patients.
Survival
The survival rates at six months, one 
year and five years were 55%, 49% 
and 24% respectively (Fig. 3).
D is c u s s io n
The course of cancer of the large in­
testine was fulminant when it com­
plicated ulcerative colitis that began 
during childhood. This was confirmed 
by the early age at which cancer devel­
oped in the present group of patients,
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Fig. la Fig. lb
Fig. 1.—(a) Grade 2 scirrhous adenocarcinoma complicating chronic ulcerative colitis. The 
desmoplastic reaction induced by carcinomas often produces a lesion that is mistaken for a 
stricture (H & E X 200). (b) Grade 4 adenocarcinoma. The incidence of such high-grade 
(Broders’ ) lesions shows a sixfold increase over that observed among “ controls” (H & E X 60).
the multiplicity of the lesions, the high- 
grade malignancy of most of the lesions, 
the frequency of regional lymph-node 
involvement and distant metastasis, and 
the low survival rate after the diagnosis 
was made. Also only one-half of the 
cancers were diagnosed clinically, and 
two-thirds already were inoperable at 
that time. Survival of our group is 
poorer (P <  0.01) than that of a large 
group of 15,388 patients with cancer of 
the large bowel (Fig. 3).19 This poor 
survival may be due to the associated 
colitis or to the young age of the pa­
tients in our series. This finding con­
firms the poor prognosis of cancer when 
it complicates ulcerative colitis that be­
gan during childhood.
The course of colitis was mild in most 
of the patients who were followed from 
childhood until they developed cancer. 
This does not necessarily mean that pa­
tients whose colitis runs a mild course 
are more prone to the cancer complica­
tion. Indeed, the group of patients in 
this study cannot be compared to a con­
trol group, free from cancer, because the 
classification of the course of disease 
was based on the history between the 
diagnosis of ulcerative colitis and the 
onset of cancer. Thus no end point for 
classification could be found for a con­
trol group, free from cancer. However, 
the present study suggests that a false 
sense of security may result when the 
course of ulcerative colitis is benign and 
indicates that such a course does not 
preclude cancer20,21 and that the high 
cancer risk in children in our series is 
not owing to the fact that the patients 
who were referred to us had more 
severe disease.
The rarity of in situ carcinoma in 
an otherwise normal colon contrasts 
markedly, in our experience, with the 
frequency of this finding in the presence 
of chronic ulcerative colitis. From this 
study, as well as in our experience with
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Fig. 2a
Fig. 2b
Fig. 2c
Fig. 2.—(a) Small cell carcinoma complicat­
ing chronic ulcerative colitis. This lesion can 
be mistaken lor malignant lymphoma (H & E 
X 125). (b) Giant cell carcinomas comparable 
to those seen in the thyroid gland represent 
another vagary in the range of carcinoma com­
plicating chronic ulcerative colitis (H & E X 
350). (c) The incidence of carcinoma in situ 
in grossly uninvolved stretches of colon in­
creases sharply with the diligence of the search 
for them. This grade 2 adenocarcinoma in situ 
was discovered in one such “normal” area (H 
& E X 200).
ulcerative colitis beginning in adult life, 
in situ carcinoma appears to represent 
an intermediate stage between the com­
monly observed mucosal hyperplasia 
characteristic of the healing of the in­
flammatory process, and the develop­
ment of infiltrating colonic carcinoma. 
In fact, at times it becomes difficult 
or impossible to be certain where regen­
erative or reparative epithelial changes 
leave off and carcinoma in situ has its 
beginnings. Indeed, multicentric carci­
noma in situ is not infrequently discov­
ered as a complication of long-standing 
chronic ulcerative colitis.
However, it would appear that these
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TABLE VI.—Classification of Cancers by Grade (Broders’) and Site of Occurrence
Grade
1 2 1 9 4 Total cases
Site Cases No. %*
Ascending colon................................... 6 4 6 4 20 21
Transverse colon (including flexures) 4 4 8 9 25 27
Descending colon................................. 2 1 1 4 8 9
Sigmoid colon...................................... 3 7 5 5 20 21
Rectum................................................. 9 3 4 5 21 22
Unknown.............................................. 1 1 1 2 5 —
Total no................................................ 25 20 25 29 99 100
% of 99................................................ 25 20 25 29
*Based on 94 cancers for which the site was recorded.
malignant transformations require 
years for their full development and be­
cause of this we do not feel capable, 
unlike Morson and Pang,22 of predict­
ing from a biopsy of healing rectal mu­
cosa which lesion will become malig­
nant. Thus, we believe prophylactic 
proctocolectomy should be considered 
when a child has had ulcerative colitis 
for 10 years with involvement of the 
entire large intestine.
Y ea rs  a f te r  d iagnosis of cancer  
Fig. 3.—Survival after the diagnosis o f can­
cer: 77 patients in whom cancer developed as 
a complication of ulcerative colitis that had 
begun in childhood compared with 15,388 pa­
tients who had carcinoma o f the large bowel 
not associated with chronic ulcerative colitis.
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R esum e
Les auteurs ont etudie un groupe de 77 ma- 
lades qui souffraient de colite ulcereuse depuis 
l’enfance et chez lesquels s’etait developpe un 
cancer du colon. Chez 96% de ces malades, 
le cancer etait apparu avant l’age de 40 ans. 
Seulement 55% ont survecu six mois, 49% 
ont survecu un an et 24% ont survecu cinq ans 
apres la decouverte du cancer. Avant l’appari- 
tion du cancer, 55% des malades n’avaient que 
peu souffert de la colite ulcereuse. Ces rensei- 
gnements corroborent le risque de cancer deja 
souligne chez des enfants atteints de colite 
ulcereuse et viennent soutenir l’indication d’une 
proctocolectomie prophylactique chez certains 
de ces malades.
PROPRIETES INHIBITRICES DU SUC GASTRIQUE HUMAIN  
SUR LA SECRETION GASTRIQUE DU R AT: 
DIFFERENCE QUANTITATIVE ^IN H IB ITIO N  
SELON CINQ ETATS PHYSIOPATHOLOGIQUES*
MARCEL J. RHEAULT, M.D., M.Sc., F.R.C.S.[C], F.A.C.S.f 
et LEON TETREAULT, M.D., M.Sc.,t Montreal, Que.
Br u n s c h w ig  et ses collaborateurs ont 
demontre dans une serie d’articles pu­
blics de 1939 a 1943 16 que les secretions 
gastriques humaines contenaient un fac- 
teur inhibiteur de la secretion gastrique. 
Dans ces etudes, le sue gastrique etait 
injecte par voie intra-veineuse a des 
chiens porteurs d’une poche de Heiden- 
hain. La secretion fundique, stimulee 
par l’epreuve du repas, etait le plus in- 
hibee lors de l’injection de sue gastrique
*Les auteurs ont ete subventionnes pour ce 
travail par Le Conseil de la Recherche Medicale 
du Canada (MA-2056).
fProfesseur adjoint de Clinique, Departement 
de Chirurgie, Hotel-Dieu de Montreal, Univer­
sity de Montreal, Montreal, Que. 
tAgrege de Recherche (Pharmacologie), Uni­
versity de Montreal, Directeur de l’Unite de 
Recherche, Hopital St-Jean-de-Dieu, Montreal, 
Que.
provenant de malades souffrant d’ane- 
mie pernicieuse: l’inhibition etait alors 
de 8 0% . Les sues de malades atteints de 
cancer gastrique, accompagne d’achlor- 
hydrie, provoquaient une inhibition de 
l’ordre de 7 2 % . Une telle inhibition etait 
beaucoup moins marquee avec des sues 
de malades affliges d’hypochlorhydrie 
idiopatique (3 6 % ) et les sues de sujets 
normaux (2 4 % ).
Menguy et Smith7 en 1960, sur une 
preparation biologique experimental 
differente, soit le rat traite par la tech­
nique de Shay, trouvaient des resultats 
differents. Les injections de substances 
inhibitrices avaient ete faites par voie 
intra-veineuse. Les auteurs concluaient 
que le malade porteur d’un ulcere duode­
nal avait un sue gastrique plus inhibi­
teur que le normo-secreteur et le porteur 
d’un cancer gastrique.
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Dans le present travail, nous avons 
utilise la technique de Shay chez le 
rat et l’injection par voie peritoneale 
d’extraits de sue gastrique humain pro- 
venant de malades atteints de diverses 
pathologies: cancer gastrique, ulcere 
gastrique, ulcere duodenal, anemie per- 
nicieuse. Deux groupes temoins furent 
de plus utilises: un premier recevant 
des extraits de secretion gastrique ve- 
nant de sujets normaux, le second ne 
recevant aucune injection intra-peri to- 
neale. Chaque malade nous a fourni 
deux types de secretions: secretion obte- 
nue dans des conditions basales et secre­
tion aspiree apres stimulation par His- 
talog. Tous les resultats ont ete soumis a 
des analyses de variance et de co-va­
riance completees par des comparaisons 
deux a deux.
Materiel et methodes
Collection du liquide gastrique
chez les patients
Un tube de Levin no 16 est installe 
sous fluoroscopie. Pendant la duree de 
la collection le patient ne doit pas avaler 
sa salive. Pour etre acceptes, les speci­
mens doivent etre libres de toute conta­
mination par du sang ou de la bile.
Les collections sont divisees en deux 
parties: (a) Collection nocturne: le 
liquide gastrique nocturne est aspire 
continuellement pendant 12 heures a 
l’aide d’une succion mecanique. Son 
volume est mesure et le specimen est 
transfere dans un bocal place dans la 
glace seche. (b) Collection apres stimu­
lation a VHistalog: apres l’injection 
sous-cutanee de 100 mg d’Histalog, les 
prelevements de liquide gastrique sont 
faits aux 15 minutes. Les secretions, 
apres la mesure de leur volume, sont 
aussi versees dans un bocal refrigere 
par de la glace seche.
Tous les specimens sont conserves au 
congelateur jusqu’au moment de leurs 
traitements.
Dialyse
Les specimens sont degeles et centri­
fuges a froid (4° C) durant deux heures 
a 2500 rpm. Le surnageant est soigneu-
sement decante dans des tubes a dialyse 
Visking 10/32. La dialyse est effectuee 
dans un bain d’eau courante durant 24 
heures, puis les tubes sont transferes 
dans un contenant d’eau distillee place 
au refrigerateur ou la dialyse se pour- 
suit durant 24 a 36 heures avec deux 
ou trois changements d’eau.
Le contenu du tube de dialyse est 
alors transfere dans des bouteilles a cen­
trifuge et centrifuge durant deux heures 
a 4° C. Le surnageant est decante (ou 
filtre a travers un papier filtre What­
man 42, si le liquide est trouble) dans 
un ballon de lyophilisation.
Lyophilisation
Les specimens sont lyophilises et la 
poudre obtenue est pesee immediate- 
ment et placee dans un petit contenant 
de verre bien scelle. Us sont gardes dans 
un dessiccateur au refrigerateur jus­
qu’au moment de leur mise en solution 
pour les dosages biologiques.
Dosages biologiques de I’activite
inhibitrice du sue gastrique
(technique de Shay)
Le rat anesthesie a Tether est pese, 
sa temperature rectale prise et une lapa- 
rotomie pratiquee. L’estomac est expose, 
le pylore ligature par un brin de soie, 
puis la paroi est refermee par un surjet 
en un plan total. Au moment de la su­
ture, on injecte dans la cavite perito­
neale le specimen de substance a etudier 
(2 mg/ml/100 g de rats), dilue dans 
un tampon phosphate de pH 7.5, 1.5N. 
La technique bien executee se complete 
en moins de cinq minutes. Les rats gar­
des dans des cages individuelles pendant 
quatre heures sont prives d’eau et d’ali- 
ments. Comme ils secretent continuelle­
ment pendant la phase interdigestive, le 
volume et 1’acidite de la secretion gas­
trique sont des variables utiles dans 
l’etude de substances inhibitrices ou sti- 
mulantes. Apres quatre heures, la tem­
perature rectale est prise et les rats 
sont sacrifies par ether. Une nouvelle 
laparotomie est faite et une pince appli- 
quee a la jonction oesophago-gastrique 
pour prevenir le reflux et la perte de sue 
gastrique. L’oesophage et le duodenum
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TABLEAU I.— Constitution des Groupes Experimentaux
Groupes experimentaux
Traitement
IP
Diagnostic des sujets ou malades 
ayant fourni le sue gastrique*Numero Denomination
I Temoin sans 
traitement
Nil —
II Temoin
Extrait de sue
gastrique
humain
Volontaires sains
Anemie pernicieuseIII Anemie
pernicieuse
IV Cancer
gastrique
Cancer gastrique
V Ulcere
duodenal
Ulcere duodenal
VI Ulcere
gastrique
Ulcere gastrique
*Chaque sujet ou malade a fourni deux echantillons de sue gastrique, le premier secrete pendant une periode 
de jeune, le second secrete apres stimulation par Histalog.
sont sectionnes et le contenu de l’esto- 
mac vide dans une eprouvette graduee 
qui est ensuite soumise a une centrifu­
gation (2,000 rpm) pendant 15 minutes. 
Le surnageant est decante, son volume 
mesure, puis l’acidite totale est deter- 
minee par une solution d’hydroxyde de 
sodium 0.5N a pH 7.5. La titration est 
faite avec un appareil automatique ra- 
dfometer; les resultats sont exprimes 
en milliequivalents (mEq) par quatre 
heures.
T r a i t e m e n t  d e s  d o n n e e s
Le travail a porte sur six groupes ex­
perimentaux identifies par le diagnostic 
des malades les constituant. Les sujets 
humains malades ou volontaires sains 
etaient des unites experimentales et a 
chacun d’eux correspondait un groupe 
de 20 rats constituant chacun des unites 
d’echantillonnage. L’activite inhibitrice 
des extraits de secretion gastrique de 
chacun des malades fut ainsi dosee de 
fa§on biologique grace a la secretion 
gastrique de 20 rats differents. La cons­
titution des groupes experimentaux est 
exposee au tableau I. Le groupe temoin 
sans traitement comprend cinq sous- 
groupes de 20 rats dont la secretion gas­
trique a ete mesuree en l’absence de 
tout traitement par extrait de sue gas­
trique humain. Le groupe temoin est
compose de cinq sous-groupes de 20 rats 
traites respectivement par des extraits 
de sue gastrique provenant de cinq vo­
lontaires sains. Le groupe anemie perni- 
cieuse a pour unite experimental trois 
malades souffrant de cette maladie et 
pour unite d’echantillonnage 60 rats, 
e’est-a-dire trois sous-groupes de 20 rats 
traites par les extraits de sue gastrique 
provenant de ces trois malades. II en 
est de meme pour les groupes cancer 
gastrique, ulcere duodenal et ulcere gas­
trique. Les malades de ces groupes expe­
rimentaux fournissent chacun du sue 
gastrique dont les extraits sont titres 
sur des sous-groupes de 20 rats.
Comme nous l’avons deja demontre8, 
le poids des rats qui servent de dosage 
biologique des inhibiteurs ou stimulants 
de la secretion gastrique, est en corre­
lation directe avec le volume total de 
l’acidite de leur secretion gastrique. II 
importe done de tenir compte de ces 
poids lorsqu’on veut utiliser la secretion 
gastrique du rat pour etudier l’influence 
des extraits de sue gastrique humain. 
Par l’analyse de variance, nous ne re- 
trouvons aucune difference significative 
entre les poids des animaux utilises pour 
l’etude des six groupes experimentaux. 
Malgre cette absence d’heterogeneite 
significative puisque le poids des rats 
est en correlation avec leur secretion 
gastrique, nous avons utilise l’analyse
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de covariance pour eviter les erreurs 
systematiques que pourrait introduire 
la variation des poids entre les groupes.
Les donnees utilisees sont done les sui- 
vantes: la variable independante X est 
la somme des poids corporels (g) des 
20 rats utilises pour titrer l’extrait < 
gastrique de chacun des sujets ou ma- D 
lades constituant chacun des groupes ® 
experimentaux; la variable indepen- §  
dante Y est la somme des volumes (ml) 2 
de secretion gastrique de ces 20 rats < 
ou encore la somme des acidites totales  ^
(mEq) de ces 20 rats. Les donnees qui 2 
caracterisent chaque unite experimen- ’« 
tale sont done les sommes des donnees «  
de chaque sous-groupe de 20 rats cor- ^ 
respondant a l’unite experimentale.
a
R e s u l t a t s  sD
Influence des extraits de sue 
gastrique humain sur le volume de la w 
secretion gastrique du rat (tableaux K 
II et III, fig. 1) §
z
On retrouve une difference haute- < 
ment significative lorsqu’on procede a d 
une comparaison simultanee des six w 
groupes. Les moyennes ajustees des §. 
sommes de volume de secretion gastri- 2 
que sont pour le groupe temoin sans < 
traitement de 87.0 ml, pour le groupe  ^
temoin de 54.4 ml, pour le groupe ane- ^ 
mie pernicieuse de 39.9 ml, pour le g
groupe cancer gastrique de 46.9 ml, pour £ 
le groupe ulcere gastrique de 53.7 ml. < 
A 1’analyse de covariance, le coefficient * 
de Fisher est de 13.18 et la probability ^ 
d’erreur de premier ordre est inferieure § 
a 0.001 (tableau II). Nous avons pousse g 
plus loin l’analyse en effectuant les 15 w 
comparaisons deux a deux possibles 3
lorsqu’il existe six groupes (tableau Z 
III). Par celles-ci il est clairement de- l 
montre (P < 0.001) que les extraits de '=: 
sue gastrique humain inhibent la secre- < 
tion gastrique du rat. En effet, les com- 2 
paraisons entre le premier groupe te- £§ 
moin sans traitement et chacun des cinq ^ 
autres groupes sont tres significatives 
et fournissent des coefficients de Fisher 
toujours superieurs a 20. Les extraits 
de sue gastrique humain ont des pro­
priety inhibitrices variables selon les
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TABLEAU III.—Influence des E xtraits de Sue Gastrique H umain sur i.e Volume de la Secretion 
Gastrique du Rat. Comparaisons Deux a Deux
II Temoin 22.60681
VI Ulcfere gastrique 23.24621 0.0116
IV Cancer gastrique 24.19511 0.8716 0.7268
III Anemie pernicieuse 33.14061 3.0632x 2.6305 0.5085
V Ulcere duodenal 54.63621 6.1720* 5.6665* 1.2969 0.0502
« P < 0.10
1
Temoin sans
II VI IV III
* P <  0.05 
f P < 0.001
traitement Temoin Ulcere
gastrique
Cancer
gastrique
Anemie
pernicieuse
diagnostics des malades qui fournissent 
ceux-ci. Les extraits de sue gastrique 
provenant de malades souffrant d’ane- 
mie pernicieuse (P < 0.05) et demalades 
souffrant d’ulcere duodenal (P < 0.10) 
sont plus inhibiteurs que les extraits de 
sue gastrique provenant de volontaires 
sains. Les extraits de sue gastrique de 
malades souffrant d’ulcere gastrique 
ne sont pas significativement differents 
des extraits de sue gastrique provenant 
de temoins, mais sont significativement 
moins inhibiteurs que les extraits prove­
nant de malades souffrant d’anemie 
pernicieuse (tableau III, fig. 1). Toutes 
les autres comparaisons possibles entre
Somme de volumes 
de secretion gastrique 
(moyenne oiustee e" ml)
»
100 r
90h
Fig. 1.—Influence des extraits de sue gastri­
que humain sur le volume de la secretion gas­
trique du rat.
l°s six groupes ne revelent aucune dif­
ference statistique.
Influence des extraits de sue gastrique 
humain ohtenus apres stimulation par 
Histalog sur le volume de la secretion 
gastrique du rat (tableaux IV et V, 
fig. 2)
Deux types de sue gastrique furent 
recueillis pour etude. Le premier dont 
nous avons discute dans le chapitre pre­
cedent est celui spontanement secrete. 
Le deuxieme type dont nous avons fait 
les extraits est celui obtenu apres stimu­
lation de la secretion par Histalog. Les 
extraits de ce deuxieme type de sue 
gastrique furent etudies de la meme 
faqon que les premiers. II existe une 
difference hautement significative entre 
les six groupes experimentaux; le coef­
ficient de Fisher est de 6.71 et la proba­
bility d’erreur est inferieure a 0.001 
(tableau IV). Les comparaisons deux a 
deux demontrent encore clairement les 
proprietes inhibitrices du sue gastrique 
humain qui persiste quand la secretion 
gastrique est stimulee par Histalog. 
Tous les groupes sont significativement 
inhibiteurs par rapport au groupe te- 
moin sans traitement. Avec ces extraits 
cependant, on ne retrouve plus aucune 
difference entre les extraits de sue gas­
trique obtenus des malades souffrant de 
differentes pathologies (tableau V, 
fig. 2).
Influence des extraits de sue gastri­
que humain sur I’acidite totale de la 
secretion gastrique du rat (tableaux 
VI et VII. fig. 3)
-J- v  # v  y  v  V  ; 4 . V ~ ^  4  t  v  V r  *■
TABLEAU IV. Influence des E xtraits de Sue Gastrique H umain Obtenu Apres Stimulation par H istalog sur le Volume de la Secretion 
_______ Gastrique du F at
Croupe
I
Temoin sans 
traitement
I I
T emoin
I I I
Anemie
pernicieuse
IV
Cancer
gastrique
V
Ulcere
duodenal
VI
Ulcere
gastrique
Nombre d ’unites experimentales = n (nombre de malades) 5 5 2 6 6 5
Nombre d ’unites d ’echantillonage = R (nombre de rats) 5 X 20 5 X 20 2 X 20 6 X 20 6 X 20 5 X 20
Donnees caracterisant les groupes de 20 
rats. A chaque unite experimentale cor­
respond Tun de ces groupes.
Moyenne des sommes de 
poids corporel (g) =  Xj. 1819.2 1828.2 1869.0 1816.2 2126.5 1816.6
Moyenne des sommes de 
volumes de secretion gas­
trique (ml) = Y j.
86.2 49.6 43.4 45.9 50.2 44.1
Moyenne ajustee des sommes 
de volumes de secretion gas­
trique (ml) = Y;.
88.2 51.3 44.0 47.9 43.1 46.1
Analyse de covariance F = 6.71 P < 0.001
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'  ABLEAU V.—Influence des E xtraits de Sue Gastrique H umain Obtenu apres 
Stimulation par H istalog sur le Volume de la Secretion Gastrique du Rat. 
Comparaisons Deux A Deux
II Temoin 16.1075f
IV Cancer gastrique 20.9173f 0.1453
VI Ulcere gastrique 20.9216f 0.3142 0.0417
III Anemie pernicieuse 13.1913* 0.3624 0.1116 0.0318
V Ulcere duodenal 22.1576f 0.7377 0.2750 0.1002 0.0049
1
Temoin sans 
traitement
II
Temoin
IV
Cancer
gastrique
VI
Ulcere
gastrique
III
Anemie
pernicieuse
* P — 0.01 
t P — 0.001
N
ovem
ber 1972 
SU
C
 G
A
ST
R
IQ
U
E
 H
U
M
A
IN
 
379
38
0 
T
H
E
 C
A
N
A
D
IA
N
 J
O
U
R
N
A
L
 O
F 
SU
R
G
E
R
Y
 
Vo
l. 
IS
* 7 f \x
TABLEAU VII. - I nfluence des E xtraits de Sue Gastrique Humain sur L’Acidite 
I  otale de la Secretion Gastrique du R at. Comparaisons Deux A Deux
11 Temoin 24.4505f
VI Ulcere gastrique 27.2044f 0.0992
IV Cancer gastrique 26.8757f 1.0825 0.6117
III Anemie pernicieuse 34.2093f 2.8350 1.9295 0.3228
V Ulcere duodenal 58.6857f 6.5369* 4.9989* 1.1855 0.1215
I
Temoin sans 
traitement
II
Temoin
VI
Ulcere
gastrique
IV
Cancer
gastrique
III
Anemie
pernicieuse
* P <0.05 
f P <0.001
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TABLEAU VI.—Influence des E xtraits de Sue Gastrique K umain sur L’Acidite T otale de la Secretion Gastrique du Rat
Groupe
I
Temoin sans 
traitement
5
I I
Temoin
I I I
Anemie
pernicieuse
IV
Cancer
gastrique
V
Ulcere
duodenal
VI
Ulcere
gastrique
Nombre d’unites experimentales = n (nombre de malades) 5 3 3 6 5
Nombre d’unites d ’echantillonnage = R (nombre de rats) 5 X 20 5 X 20 3 X 20 3 X 20 6 X 20 5 X 20
Donnees caracterisant les groupes de 20 
rats. A chaque unite experimentale cor­
respond 1’un de ces groupes.
Moyenne des sommes de 
poids corporel (g) = Xi. 1819.2 1846.6 1662.7 1969.7 1889.2 1891.2
Moyenne des sommes _
d’acidite totale (mEq) = Y j . 10.4 6.1 3.8 5.3 4.0 5.9
Moyenne ajustee des sommes 
d ’acidite totale (mEq) = V i. 10.5 6.1 4.3 5.0 3.9 5.8
Analyse de covariance F = 14.05 P <  0.001
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Les effets des extraits de sue gastri- 
que sur 1’acidite totale de la secretion 
gastrique du rat sont comparables a 
ceux obtenus sur le volume des secre­
tions gastriques. La comparaison simul- 
tanee des six groupes est significative 
(F = 14.05, P <  0.001, tableau VI) et 
les comparaisons deux a deux demon- 
trent le pouvoir inhibiteur du sue gas­
trique humain (P < 0.001, tableau 
VII). Les extraits de sue gastrique de 
malades souffrant d’ulcere duodenal 
sont significativement plus inhibiteurs 
que les extraits de sue gastrique pro- 
venant de volontaires sains ou de ma­
lades souffrant d’ulcere gastrique (P 
< 0.05, tableau VII, fig. 3).
Influence des extraits de sue gastrique 
humain obtenus apres stimulation par 
Histalog sur I’acidite totale de la 
secretion gastrique du rat (tableaux 
VIII et IX, fig. U)
Le sue gastrique humain quand la 
secretion est stimulee par Histalog a 
sur I’acidite totale de la secretion gastri­
que du rat les memes effets que sur le 
volume de cette secretion. La comparai­
son simultanee des six groupes produit 
un coefficient de Fisher tres significatif 
(P < 0.001, tableau VIII) et le sue 
gastrique humain a des proprietes inhi- 
trices tres claires (P < 0.001, tableau 
IX). Aucune difference statistique n’est 
retrouvee pour les neuf autres compa­
raisons possibles entre les groupes 
experimentaux.
D is c u ss io n
Les resultats de ce travail demontrent 
1’existence d’un facteur gastrique in­
hibiteur de la secretion gastrique avec 
une probability d’erreur inferieure a 
0.001. Cette etude confirme done les 
conclusions de Brunschwig, Menguy et 
leurs collaborateurs.
Des les premieres publications sur 
1’existence de proprietes inhibitrices de 
sue gastrique humain, on a fait etat de 
differences quantitatives entre les pou- 
voirs inhibiteurs des sues gastriques de 
malades souffrant de pathologies diver- 
ses.1'7 De plus, selon les dosages biologi-
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TABLEAU IX.— Influence des E xtraits de Sue Gastrique H umain Obtenu apres Stimulation par 
H istalog sur l ’acidite Totale de la Secretion Gastrique du Rat. Comparaisons Deux a Deux
II Temoin 21.0177*
VI Ulcere gastrique 24.6525* 0.1447
IV Cancer gastrique 26.4925* 0.1283 0.0015
V Ulcere duodenal 29.9461* 1.1596 0.4980 0.5956
III Anemie pernicieuse 21.8013* 1.4601 0.8470 0.9450 0.1306
I
Temoin sans 
traitement
II
Temoin
VI
Ulcere
gastrique
IV
Cancer
gastrique
V
Ulcere
duodenal
* P <  0.001
ques utilises e t les especes anim ales en 
cause, l’o rd re  de puissance inhibitrice 
des sues gastriques d’un e ta t pathologi- 
que a l’a u tre  varie. Avec la technique de 
la poche de Heidenhain, chez le chien, 
l’injection intra-veineuse de substances 
inh ib itrices obtenues p a r precipitation 
a  l’alcool, indique que le pouvoir inhi- 
b iteu r du sue gastrique est le plus m ar­
que dans 1’anem ie pernicieuse; il Test 
m oins dans le cancer gastrique et il est 
au plus bas chez les su jets norm aux.1"5 
Les au teu rs  qui se sont servis du ra t  et
Somme d 'a c id ite to ta l*  
de s e c re tio n  g a s tr iq u e  
<m oyenn* o ju s te e  en mEq)
sans p e rn ic ieu se  g a s tr iq u e  duodena! g a s tr iq u e
tra i te m e n t
Fig. 4.—Influence des ex tra its de sue g a s tr i­
que hum ain obtenus apres stim ulation p ar His- 
tolog su r l’acidite totale de la secretion gas­
trique  du ra t.
de la technique de Shay proposent un 
ordre decroissant d iffe ren t: ulcus duo­
denal en prem ier lieu, puis su jets nor- 
maux et enfin cancer de l’estomac. Les 
diverses techniques de p reparation  de 
l’ex tra it, les voies d’adm inistration va­
riables et les dosages biologiques diffe- 
ren ts expliquent peut-etre ces conclu­
sions en partie  contradictoires. Il reste 
aussi fo rt possible qu’il ne s’agisse enfin 
que de fluctuations d’echantillonnage 
qui n ’auraien t pas ete controlees par les 
methodes statistiques appropriees.
Dans la presente experience, que Ton 
considere le volume de secretion gastri­
que des ra ts  ou leur debit d’acide, la 
comparaison simultanee des six groupes 
dem ontre toujours une heterogeneite si­
gnificative, au tan t avec les ex tra its  de 
sue gastrique de base qu’avec les ex­
tra its  de sue gastrique obtenus apres 
stim ulation par Histalog. Avec les deux 
types de mesures, volume et debit acide, 
les ex tra its  de secretion gastrique hu- 
maine, qu’ils viennent de m alades ou de 
su jets normaux, ont tou jours un pou­
voir inhibiteur hautem ent significatif. 
On retrouve en effet tou jou rs une inhi­
bition hautem ent significative pour les 
ex tra its  de sue gastrique hum ain par 
comparaison avec les secretions de ra ts  
tem oins ne recevant aucun tra item ent. 
La recherche des differences entre les 
pouvoirs inhibiteurs de sue de malades 
souffran t de diverses pathologies n ’a 
pas donne de resu lta ts significatifs lors- 
que les secretions hum aines ont ete ob­
tenues apres stim ulation par Histalog, 
que le volume ou le debit d’acide des se-
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cretions de ra ts  fussen t pris comme va­
riable de mesure. 11 nous semble logique 
de conclure que 1’utilisation de secre­
tions basales serait plus efficace que l’u- 
tilisation de secretion gastrique obtenue 
apres stim ulation pharmacologique dans 
la recherche du pouvoir inh ib iteur d’ex- 
tra i ts  de diverses secretions gastriques. 
II en est tout au trem ent avec les ex tra its  
de sue gastrique obtenus dans des condi­
tions basales. En u tilisan t le volume 
comme variable, la puissance inhibitrice 
des sues gastriques hum ains va decrois­
san t selon l’ordre suivant: ulcere duo­
denal, anemie pernicieuse, cancer g a s tr i­
que, ulcere gastrique, tem oins norm aux. 
Cet ordre ne peut cependant e tre  e x tra ­
pole a l’ensemble des populations mala- 
des. Seules trois comparaisons deux a 
deux sont statistiquem ent significati- 
ves: dans 1’ulcere duodenal et dans l’ane- 
mie pernicieuse les secretions gastriques 
sont plus inhibitrices que celles du su jet 
sain ; chez l’anemique, ce pouvoir inhi­
b iteur est plus m arque que chez le ma- 
lade qui souffre d’ulcere gastrique. En 
u tilisan t des preparations biologiques 
differentes, Brunschwig d’une p a rt a 
deja demontre le pouvoir plus inh ib iteur 
du sue gastrique de m alades sou ffran t 
d’anemie pernicieuse, Menguy d’au tre  
p a rt a deja aussi fa it une observation 
semblable pour le sue de malades souf­
f ra n t d’ulcere duodenal.
Si le debit acide des secretions g a s tr i­
ques du ra t est utilise comme param e- 
tre , on retrouve le meme ordre decrois­
san t des pouvoirs inhibiteurs du sue g as­
trique que celui deja decrit pour le volu­
me des secretions gastriques. Comme 
precedemment, le sue des patien ts ayan t 
un ulcere duodenal est plus inh ib iteur 
que le sue des temoins e t le sue de ceux 
qui souffrent d’ulcere gastrique. On ne 
retrouve plus par contre de difference 
significative entre les anemiques e t les 
tem oins.
R e su m e
Les proprietes inhibitrices du sue g a s ­
trique hum ain sur la secretion g a s tr i­
que de ra ts  ont ete etudiees chez cinq 
groupes de su jets: su jets tem oins no r­
maux, m alades so u ffran t d’ulcere duo 
denal, d’ulcere gastrique , de cancer gas­
trique e t d ’anemie pernicieuse. Ces p ro­
prietes inhibitrices on t ete dem ontrees 
avec une probability d ’erreu r in ferieure  
a 0.001 au tan t su r le volume de secre­
tion que su r le debit acide to tal. Les sues 
gastriques hum ains obtenus sans stim u­
lation ont des pouvoirs inh ib iteurs si- 
gnificativem ent variab les selon les dif- 
feren ts e ta ts  physiopathologiques etu- 
dies. Ces differences s ta tis tiques  ne sont 
plus retrouvees lo rsqu’on utilise le sue 
gastrique humain obtenu par stim ula­
tion avec Histalog.
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Summary
The property of human gastric juice to 
inhibit gastric secretion in the rat has been 
studied using, as a source of the material, five 
different groups: normal controls, patients 
suffering from duodenal and gastric ulcers, 
gastric carcinoma and pernicious anemia.
The inhibition of the volume as well as the 
acid output of the rats’ gastric secretions was 
demonstrated with a probability of error of 
less than 0.001.
The human gastric juice obtained without 
stimulation produces inhibition which varies 
significantly from one disease to another. 
These differences are no longer valid when 
Histalog-stimulated human gastric juice is  
used.
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SPHINCTEROPLASTY, AN INDIVIDUALIZED OPERATION: 
AN ANATOMIC STUDY IN AUTOPSY MATERIAL
W. GORDON BEATTIE, M.D., F.R.C.S.[C], F.A.C.S.‘  and 
M. KUPPUSAMI, M.D., C.R.C.S.[C], Ottawa, Ont.
E a r l y  in this century many surgeons 
studied the choledochoduodenal region 
and particularly the ampulla of Vater, 
in a search for the cause of pancreatitis. 
More recently the problems posed by re­
tained common duct stones and chronic 
pancreatitis have continued to challenge 
surgical investigators working in this 
area.
Opie in 190U demonstrated the roh 
of bile in experimental pancreatitis and, 
at autopsy, demonstrated pancreatitis in 
a subject with an obstructed ampulla 
due to a small stone. He suggested that 
bile refluxing into the pancreas caused 
the pancreatitis. Archibald,2,3 studying 
models of experimental pancreatitis, 
concluded that the cause was spasm of 
the sphincter of Oddi and suggested 
that the sphincter be sectioned to treat 
certain patients with pancreatitis. He 
was the first surgeon to do a sphinc­
terotomy. Archibald also drew attention 
to the work of Oddi, who clarified the 
anatomy and physiology of the sphinc­
ter that guards the entrance of the 
common duct into the duodenum.3 In 
1937 Doubilet and Colp4 demonstrated 
that the sphincter of Oddi resists the 
flow of bile. Later, Doubilet and Mul­
holland3, 6 applied sphincterotomy to the 
treatment of recurrent pancreatitis. 
Ochsner, commenting on Doubilet’s 
presentation in 1948, suggested that the 
ductal mucosabe sutured to the duodenal 
mucosa to prevent stricture formation. 
McPhedran et al.7 studied the histology 
•of the ampulla and confirmed the pres­
ence of fronds of duodenal mucosa 
hanging into the lumen of the ampulla 
originally described by Fatselt.8 Al­
though these fronds may assist in pre­
venting reflux, they act more as a one­
way valve than as a cause of resist­
ance to flow of bile into the duodenum.
In 1959 Eiseman et al.’ proved ex-
* Professor of Surgery, University of Ottawa; 
■Chairman, Division of Surgery, Ottawa Civic 
Hospital, Ottawa, Ont.
perimentally and clinically that sphinc­
terotomy does not permanently lower 
resistance to fluid flow through the am­
pulla of Vater. Boyden10 precisely de­
fined the length of the choledochal 
sphincter in man and demonstrated that 
sphincterotomy, as described by Dou­
bilet and Mulholland, did not lower the 
resistance to bile flow through the am­
pulla because it did not cut all the 
sphincter. To eliminate the sphincter’s 
action completely, Jones et al.nls per­
formed sphincteroplasty. They divided 
all the muscle, removed a wedge of am- 
pullary wall and precisely opposed com­
mon duct to duodenal mucosa to prevent 
leakage. Bartlett and Nardi18 described 
a similar operation, though they named 
it “transduodenal sphincterotomy” . In 
addition, they sectioned the septum 
dividing the pancreatic duct and bile 
duct. Vajcner, Grossling and Nicoloff17 
demonstrated the permanent effect of 
their sphincteroplasty, an operation es­
sentially the same as that of Jones.
Serious complications such as duo­
denal leak or pancreatic injury may 
occur with extended section of the 
sphincter if the length of the sphinc­
teroplasty extends beyond the duodenal 
wall. We carried out the study described 
below to determine the anatomic vari­
ables that govern sphincteroplasty.
Material and Method
In 54 subjects coming to autopsy the 
intramural course of the common bile 
duct was studied, noting the length (ex­
tent) of the sphincter, direction of duct 
and its relation to the pancreas. We did 
the 1-cm. incision sphincterotomy of 
Doubilet and Mulholland and the more 
extensive sphincteroplasty of Jones; the 
latter was modified in the light of 
knowledge gained as the study pro­
gressed.
The technique of sphincteroplasty 
was as follows: the duodenum was fully 
mobilized to its embryonic midline posi-
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tion and rotated anteriorly. The papilla 
was incised on its most lateral aspect in 
the 11 o’clock direction. The transition 
line where the pink mucosa of the 
sphincter met the yellow honeycombed 
mucosa of the bile duct within the wall 
of the duodenum indicated the proximal 
end of the sphincter. The length of the 
incision could then be determined pre­
cisely. No wedge of sphincter or mucosa 
was removed.
At autopsy in five cases the effects 
of these procedures were correlated 
with radiographs of common-duct drain­
age obtained by injecting barium into 
the common duct before and after the 
specific operative procedures.
A n a t o m ic a l  O b s e r v a t io n s
In all 54 autopsy specimens the bile 
and pancreatic ducts opened into the 
duodenum through the duodenal papilla, 
situated on the concave side of the sec­
ond part of the duodenum an average 
of 9.1 cm. (7.5 to 12 cm.) from the 
pylorus. The average length of the pa­
pilla (7.5 mm.) did not correlate with 
the length of its sphincter.
In its retropancreatic course, the 
common bile duct is buried in the head 
of the pancreas and covered posteriorly 
by a thin layer of pancreatic tissue. At 
its distal end the duct inclines slightly 
anteriorly and opens at the posterior
Fig. 1.—Pancreatic head turned anteriorly 
(with Kocherized duodenum removed).
part of the pancreatic surface of the 
duodenum. In Fig. 1 the pancreatic 
head is turned anteriorly as in a fully 
mobilized duodenum, with the duode­
num removed; the figure shows the 
ampullary end of the common duct as 
it lies in the posterior part of the duo­
denal sulcus of the pancreatic head. 
Thus, as visualized during operation, 
the ampulla is directed interiorly and 
slightly anteriorly in the 11 o’clock posi­
tion. The pancreatic duct opens on the 
intramural portion of the medial w^ all 
of the ampulla.
Tig- 2.—Opened common duct and sphincteric area. Note the abrupt transition zone.
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Fig. 3.—Length of the intramural common 
duct and sphincter of Boyden.
The sphincteric area is thicker than 
the rest of the common bile duct wall as 
can be seen in the longitudinally opened 
common duct (Fig. 2). The area pre­
sents a smooth pink appearance in con­
trast to the slightly yellowish honey­
combed surface of the mucosa of the 
common duct. There is an abrupt transi­
tion at this junction, which helps to 
identify the proximal limit of the 
sphincter when examining the open 
duct.
P A N C R E A T I C  T I S S U E
Fig. 5.—Identification of structure shown in 
Fig. 4.
The length of the intraduodenal por­
tion of the common bile duct averages 
16 mm. (10 to 23 mm.), being slightly 
longer (1 mm. average) than the full 
length of the sphincter of Boyden which 
averages 15 mm. (10 to 20 mm.) (Fig. 
3). On microscopic examination the 
sphincter muscle always lies within the 
duodenal wall (Figs. 4 and 5). Pancre­
atic tissue lies adjacent to the duodenal 
wall near the common bile duct entrance 
and thus is vulnerable to inadvertent 
injury from a sphincterotomy incision 
that extends beyond the upper limit of 
the sphincter (Fig. 5).
Fig. 4.—Low-power microscopic section of the intramural common duct, sphincter of 
Boyden, duodenal wall and pancreas.
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Fig. 6.—Barium x-ray of common duct after 
sphincterotomy.
Fig. 7.—Barium x-ray of common duct after
sphincteroplasty.
In all five autopsy cases the sphincter 
was demonstrated to be competent by 
barium x-ray studies before the muscle 
was sectioned. Therefore we could make 
a gross assessment of the effects on 
sphincteric competence of sphinctero­
tomy and sphincteroplasty. Following 
routine sphincterotomies the radio­
graphs clearly demonstrate the persist­
ently narrowed segment of the lower 
end of the common duct within the duo­
denal wall (Fig. 6). Films made after 
sphincteroplasty (Fig. 7) show that the 
diameter of the bile duct as it opens into 
the duodenum is increased and now al­
most equals the diameter of the com­
mon duct itself.
S u m m a r y  a n d  C o n c l u s io n
The intraduodenal course of the com­
mon bile duct was studied in 54 autopsy 
cases. It was demonstrated that ade­
quate sphincteroplasty can be tailored 
to the individual patient. This is at­
tained by noting the extent of the 
sphincter of Boyden, precisely identi­
fied by the junction of the smooth pink 
mucosa overlying the sphincter and the 
yellowish honeycombed mucosa of the 
lower end of the common duct. The 
junction always lies within the duodenal 
wall. Limiting the extent of the incision 
to this landmark lessens the possibility 
of duodenal leak and injury to the 
pancreas. In autopsy specimens sphinc­
teroplasty proved to be superior to 
sphincterotomy in providing the widest 
diameter at the lower end of the com­
mon duct.
The authors would like to thank Dr. M. O. 
Klotz for his co-operation in providing un­
limited access to the autopsy material. Our 
appreciation is also expressed to Mrs. M. Clark 
for secretarial assistance.
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R esum e
Les auteurs ont eu l’occasion d’etudier l’ana- 
tomie de la region choledocho-duodenale au 
cours de 54 autopsies. Cette region est d’une 
importance toute particuliere pour le chirur- 
gien soucieux d’eviter les problemes de la pan- 
creatite et des calculs choledociens. Ils ont de- 
montre qu’il est possible de modifier la sphinc- 
teroplastie pour l’adapter aux besoins de cha- 
que malade. Ils font remarquer qu’il est facile 
de mesurer avec precision la longueur du 
sphincter de Boyden, grace a la jonction de la 
muqueuse rosatre recouvrant le sphincter avec 
la muqueuse jaunatre alveolee de la portion 
inferieure du choledoque. Cette jonction siege 
toujours au sein de la paroi duodenale. En li- 
mitant l’incision a ce repere, on reduit ipso 
facto le risque de suintement duodenal et de 
lesion au pancreas.
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CLINICAL TRIAL OF A NEW ABSORBABLE SYNTHETIC 
SUTURE MATERIAL: POLYGLYCOLIC ACID*
PRANK W. TURNER, M.B., Ch.B., M.Sc., F.R.C.S.[C], F.A.C.S., 
WILLIAM A. GRISWOLD, B.Sc., M.D., HERBERT W. JANZEN, M.Sc., M.D., 
JOHN F. MILNER, B.Sc., M.D. and LEONARD F. RIVERS, B.Sc., M.D.,
Edmonton, Alta.
A n ideal suture must be strong enough 
to maintain the tissues in apposition 
until sufficient collagen has been laid 
down to provide an intrinsically strong 
wound. Thereafter, because the suture 
is not needed and its continued presence 
may be harmful, natural dissolution is 
advantageous. While the suture is pro­
viding strength to a wound, it should in­
terfere as little as possible with wound 
healing. It should not provoke a foreign- 
body response and should occupy little 
space. From the practical viewpoint the 
suture material should be easy to handle 
and, when knotted, the knots should 
remain secure. The hospital administra­
tor will expect it to be cheap and to have 
a long shelf life.
Until recently none of the available 
suture materials met these demands. 
Some of the newer synthetic materials 
provide great strength and relative tis­
sue inertness but are not absorbed. In 
fact the only successful absorbable su­
ture, catgut, has been in use since the 
time of Galen.1 Unfortunately catgut 
varies widely in its strength and ab­
sorbability, and frequently causes an 
intense local tissue reaction.
A new synthetic absorbable suture 
material, a polymer of glycolic acid, is 
now available which is said to combine 
the qualities of strength, tissue inert­
ness and absorbability while being easy 
to handle. The present study was insti­
tuted to test the validity of these claims.
S u t u r e  M a t e r ia l
Polyglycolic acid (PGA) t is the homo­
polymer of glycolic acid (hydroxyacetic 
acid). The suture made from it is non­
toxic, non-collagenous and absorbable.
•From the Division of General Surgery, De­
partment of Surgery, University of Alberta 
Hospital, Edmonton, Alta. 
fDexon, supplied by Cyanamid of Canada 
Limited (Davis & Geek), Montreal, Que.
It appears to have several advantages 
over catgut yet retains many of the 
desirable features of a non-absorbable 
suture. This synthetic polymeric fibre 
has the unique property of predictable 
progressive absorption. The polyester is 
extruded to form continuous filaments 
which are then braided into sutures of 
different diameters. It possesses a 
“ straight pull” tensile strength of 77,- 
800 psi, superior to that of catgut 
(54,600 psi), silk (62,400 psi), and cot­
ton (48,000 psi), but less than that of 
Dacron (115,000 psi). However, its 
“knot-pull” tensile strength is equiva­
lent to that of Dacron and superior to 
that of silk, cotton and catgut.1
In animal studies PGA sutures have 
had greater strength than catgut at 
seven and 11 days but the values were 
substantially similar at 15 days. The 
time required for complete absorption is 
similar to catgut— approximately 60 
days.1,2 Tissue reaction is consistently 
less with PGA than with catgut.1'4 In 
studies in both rabbits and dogs, PGA 
did not interfere with the normal pro­
cess of wound healing. The breaking 
strength of tissues sutured with PGA 
and an equivalent size of catgut was 
similar in both rabbits and dogs.1' 2
In metabolic studies, 14C-labelled PGA 
was completely absorbed from the im­
plantation site by 128 days. The 14C label 
was recovered principally from the 
urine and expired air. There was no in­
dication of selective concentration in 
any one site.2 Toxicity studies using 80 
times the equivalent amount that might 
be left in a patient after operation have 
been entirely negative. Teratologic stud­
ies in rabbits have not demonstrated 
any effect on the mother, fetuses or on 
the incidence of malformation.
In previous clinical studies wounds 
have healed well and most investigators 
report that PGA is extremely strong,
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easy to handle and produces minimal 
reaction.4'7
Present study
A clinical trial was done in the Uni­
versity of Alberta Hospital, Edmonton, 
Alberta, to obtain first-hand experience 
with this suture and to add to the num­
ber of controlled studies.
The suture was used only in patients 
undergoing elective surgery and an in­
formed consent was obtained from all of 
them. Because the effect of gastroin­
testinal secretions (saliva, gastric juice, 
bile, pancreatic juice, succus entericus) 
on PGA is unknown we did not place 
sutures in contact with these fluids, 
and we did not use it in pregnant wom­
en or in children.
Because clinical studies of wound 
healing are difficult enough without in­
troducing unnecessary variables, pa­
tients with local or systemic disease 
that might complicate wound healing 
were excluded, for example those re­
quiring large amounts of corticosteroids, 
those in advanced uremia and those who 
had previously undergone local irradia­
tion to the operative site. We included, 
however, those with the common haz­
ards of obesity, chronic cough and 
malignant disease.
Thirteen members of the general 
surgical staff participated in this study 
and used the suture on a trial basis.
M ethod
The resident on the surgical service 
allotted 200 patients to either the ex­
perimental or the control group on an 
alternate basis. We considered this sat­
isfactory because the choice of suture 
material was not dictated by clinical 
factors.
In patients in the experimental group 
only PGA suture or ligature material 
was used throughout. In the control 
group the surgeon used his customary 
suture material or combination of ma­
terials—other than PGA. He retained 
the right to use materials other than 
PGA in the experimental group if he 
thought this necessary. If he did, the
patient was removed from the study.
The suture was evaluated from three 
aspects.
(1) The patient and his wound were 
evaluated where possible at 24 hours, 
five to seven days and six to eight weeks 
postoperatively. Patients failing to 
attend for the six- to eight-week exami­
nation were dropped from the study. 
Particular attention was paid to the pro­
gress of wound healing, e.g. the pres­
ence or absence of edema, cellulitis, 
suppuration, seroma, hematoma and a 
healing ridge. In a general way some 
attempt was made to determine marked 
deviations from normal in pain and rate 
of healing.
(2) An attempt was made to deter­
mine any unusual systemic response. 
Because Morgan7 had demonstrated an 
occasional unexplained elevation of 
SGOT after the use of PGA we meas­
ured this enzyme before and after op­
eration in all patients. In addition the 
leukocyte count, sedimentation rate and 
electrophoretic pattern of serum pro­
tein were measured before and after.
(3) At the conclusion of the study 
the 13 surgeons completed a question­
naire concerning the strength of the su­
ture, the reaction it produced in tissues, 
its absorbability and its handling qual­
ities. They were asked specifically about 
its knot-tying properties and the 
amount of tissue drag. (Tissue drag 
refers to the ease with which the suture 
slides through tissues.)
Results
Two hundred patients entered the 
study. Fifteen were lost to follow-up 
and were excluded. Eight were dropped 
from the study because the surgeon used 
a mixture of PGA and conventional 
sutures. Two were lost because of in­
complete records and one was excluded 
because she had received irradiation to 
the wound before operation.
Of the 174 patients available for 
analysis, 90 had been exposed only to 
PGA. Eighty-four patients served as 
controls; in these the surgeon used his 
own choice of suture material excluding 
PGA. Table I shows the procedure per-
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TABLE I.—Allocation of Patients to the 
Experimental (PGA) and Control Groups
Procedure
PGA
No. of patients
Control
No. of patients
Cholecystectomy 35 33
Appendectomy 2 1
Breast biopsy 21 16
Varicose veins 17 17
Head and neck
operations 9 5
Herniorrhaphy 6 12
Total 90 84
formed and the distribution between the 
experimental and the control groups. 
The discrepancies in patient distribu­
tion between the two groups are the 
result of rejection of patients for the 
reasons given above, e.g. in many pa­
tients undergoing herniorrhaphy the 
surgeon would not use an absorbable 
suture.
W o u n d  H e a l in g
The wound complications were sim­
ilar in the two groups (Table II). Two 
wounds became infected in both the 
PGA and the control groups. In the 
PGA group one was a small stitch ab- 
cess about a suture that had been left in 
the skin for 12 days. The second infec­
tion developed in an obese patient with 
a recurrent leiomyosarcoma of the ute­
rus and an incisional hernia. The sur­
geon did a keel type of repair but the 
wound became infected and broke down.
TABLE II.— Incidence of W ound Complications 
in the Experimental (PGA) and Control 
Groups
Complication PGA Control
Infection............................ 2 2
Seroma.............................. 0 3
Hematoma........................ 3 2
Dehiscence........................ 1 0
Incisional hernia....... / . . . 1(?) 0
Hypertrophic scar. . / . . . . 4 3
Total no. of complications 10* 10
Total no. of patients........ 90 84
Overall percentage of 
wound complications....... 11% 12%
*One patient appears twice—an infected wound 
which subsequently dehisced.
Among the control patients two had 
stitch abcesses; one of them had mul­
tiple abscesses at the site of catgut su­
tures.
None of the PGA patients developed 
seromas although three of the control 
patients did. Three PGA patients devel­
oped hematomas— one, at the site of a 
breast biopsy, required evacuation and 
resuturing 24 hours later. Two control 
patients developed hematomas and one 
of these after a cholecystectomy had to 
be evacuated in the ward. The other 
hematomas in both groups were minor 
and did not interfere with wound heal­
ing.
Four PGA patients and three controls 
developed hypertrophic scars at six 
weeks.
TABLE III.— A lterations in Laboratory Para­
meters Observed in the PGA and the C ontrol 
Groups S ix Weeks After Operations
PGA Control
No. with unexplained ele­
vation in leukocyte 
count (>10,000/c.mm.) 7 5
No. with unexplained ele­
vation in sedimentation 
rate (>  15 mm. in one 
hr.)..................................... 14 8
No. with unexplained ele­
vation in SCOT (>  50 
units/ml.).......................... 4 5
We found no evidence that PGA al­
tered the rate of wound healing or pro­
duced a less painful wound, but con­
sistently there was less reaction in 
wounds sutured with PGA. The absence 
of edema and erythema around the ma­
terial was quite remarkable.
Systemic Response (Table III)
At the six-week follow-up seven pa­
tients in the PGA group and five pa­
tients in the control group had leukocyte 
counts between 10,000 and 15,000/c.mm. 
All had had normal leukocyte counts 
before operation. In none was there an 
obvious cause.
Fourteen patients in the PGA group 
and eight patients in the control group 
who had normal preoperative sedimen­
tation rates had rates of greater than 15
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mm. in one hour at the six-week exami­
nation. In none of these patients was 
there an obvious explanation.
Four patients in the PGA group and 
five controls who had normal preopera­
tive levels had an SCOT greater than 50 
units/ml. at six weeks. Again there was 
no obvious cause and in none did the 
SGOT exceed 150 units/ml.
None of the patients in either group 
had detectable changes in the protein 
electrophoretic pattern.
Evaluation of the Suture Material
by the Participating Surgeons
Of the 13 participating surgeons, two 
had no experience with the suture and 
one was too involved with the study to 
express an unbiased opinion. This as­
sessment is therefore based on the 
opinion of 10 surgeons.
All 10 agreed that PGA suture had 
strength that was more than adequate.
Five believed that the tissue reaction 
to PGA was less than to catgut. Two 
considered the reaction to be about the 
same. Three were unwilling to express 
an opinion.
Since no one reopened a wound that 
had been closed with PGA, none could 
express an opinion concerning its ab­
sorbability.
Six surgeons considered the knot- 
tying properties of PGA to be inferior 
to those of catgut. However, two be­
lieved it to be equivalent and two more 
considered that PGA was superior. 
Seven surgeons felt that PGA produced 
more tissue drag than catgut, two felt 
it was about the same, and one was 
unwilling to express an opinion.
Three of the 10 surgeons said that 
they would not continue to use the su­
ture routinely in its present form, be­
cause its handling properties and 
knot-tying qualities were inferior or 
because the suture offered no advantage 
over catgut.
The surgeons were asked particularly 
to compare PGA and catgut because it 
is the latter that PGA is designed to 
replace. Four surgeons said that they 
would use it to replace catgut. Three 
other surgeons said that they would
continue its use only in certain highly 
selected instances.
Discussion
Because earlier studies suggested that 
PGA was satisfactory for abdominal 
wound closure4*5*7 we used the suture 
for other procedures in different parts 
of the body to obtain the widest possible 
experience and to detect any effect PGA 
might have on wound healing.
In those patients in whom it was 
used, PGA was used alone so that any 
evidence of systemic toxicity might be 
clearly recognized.
The overall wound complication rate, 
11%, was identical in both experimental 
and control groups. No difference was 
detected in the complications occurring 
in the two groups and the infection rate 
was low in both.
Hematomas formed in three of the 
PGA wounds and two of the controls. 
As might be expected the surgeons 
attributed the hematomas in the PGA 
group to difficulties in tying the suture. 
This appeared to have some validity 
because the suture material is inelastic, 
does not slip and is unforgiving to the 
slip - knot - tying surgeons. However, 
there is no problem when a square knot 
is laid down properly. The two hema­
tomas in the control group weaken this 
criticism of PGA. Initially we thought 
there were fewer hypertrophic scars in 
the PGA group but the final analysis 
did not substantiate this. Anscombe, 
Hira and Hunt5 found no keloids in 120 
wounds sutured with PGA while three 
of 82 control wounds developed keloids.
None of the abdominal wounds su­
tured with PGA dehisced sufficiently to 
require resuturing.
Those surgeons who used this ma­
terial concluded that PGA was stronger 
and caused less tissue reaction than 
catgut. PGA seems to meet the basic 
requirements of an ideal suture in that 
it is strong, absorbable and does not 
iritate the tissues. However, most 
surgeons took issue with the handling 
qualities of the suture. They felt that 
its knot-tying properties were inferior
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to those of catgut. Specifically PGA 
demands accurate and precise knot- 
ty ing as has been commented upon by 
others.4,5> 7 E arly  in the  study several 
surgeons observed th a t PGA produced 
more tissue drag. However, w ith g rea t­
er experience, seven of the 10 concluded 
th a t the overall handling properties 
were acceptable.
This study provides evidence th a t 
polyglycolic acid su tu re  provides a t 
-east as good wound healing as conven­
tional su ture m aterial. I ts  properties of 
strength, absorbability  and m inim al 
tissue reaction suggest tha t it  is su­
perior to catgut and non-absorbable 
sutures. Its  only draw back appears to 
be its unusual handling qualities neces­
sita ting  g rea ter care in knot-tying and 
a little patience in its use. W hether th is 
defect will present an insurm ountable 
barrier to the  average surgeon rem ains 
to be seen.
S u m m a r y
A clinical tria l of polyglycolic acid 
(Dexon) su ture m ateria l has been ca r­
ried out. Polyglycolic acid (PGA) was 
the only su ture used in 90 patients un­
dergoing a varie ty  of general surgical 
procedures. In 84 control patients, con­
ventional suture m aterial was used. The 
overall incidence of wound complica­
tions, 11%, was the same in both groups. 
No evidence of system ic toxicity was 
found. Some surgeons withheld accept­
ance of the su ture m aterial because of 
its slightly d ifferen t handling qualities. 
W ith experience th is did not present a 
m ajor problem. Polyglycolic acid, with 
its properties of streng th , absorbability
and m inim al tissue reaction, rep resen ts 
a  sign ifican t advance over presently  
available su ture m aterial.
W e w ish  to  th an k  and  acknow ledge the 
co n stan t su p p o r t and  guidance of D r. R. A . 
M acbeth, P ro fesso r and  H ead of the  D e p a r t­
m en t o f S u rg e ry . W e w ould also  like  to  th a n k  
o u r g en e ra l su rg ica l colleagues fo r  th e ir  w ill­
ingness to  p a rtic ip a te  and  the  op era tin g -ro o m  
s ta f f  o f th e  U n iv e rs ity  H o sp ita l fo r  th e ir  
fo rbearance .
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R e s u m e
Un fil a  su tu re r  f a i t  d ’acide po lyglycolique 
(D exon) a  e te  le seul f il u tilise  chez 90 p a ­
tie n ts  a y a n t sub i d iverses o p era tions genera tes . 
Chez 82 tem oins, les fils  a  s u tu re r  c lassiques 
on t e te  em ployes. L a frequence  g lobale  des 
com plications au  n iveau  de la p la ie  o p e ra to ire  
a e te  de 11% dans les deux groupes. On n ’a 
observe aucun  signe de tox ic ite  genera te .
Les a v a n ta g e s  in h e ren ts  a  Tacide polyglyco­
lique, p a rticu lie rem en t sa  re s is tan ce , son ab ­
so rbability  e t  le degre m inim e de reac tio n  on t 
e te  m is p lus ou m oins en doute p a r  quelques 
ch iru rg ien s qui rep u g n a ien t a le m an ipu le r.
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B O O K  R E V I E W S
ADVANCES IN SURGERY. Vol. 5. Edited
by Claude E. Welch and James D.
Hardy. 354 pp. Illust. Year Book Medical
Publishers, Inc., Chicago, 1971. $18.50.
Various reviews of diverse topics are in­
cluded in this volume.
Parks gives an excellent review of the 
anorectal region and a detailed description 
of submucous hemorrhoidectomy. Pro­
bably of most interest to the average sur­
geon is the account of the mechanism 
whereby symptoms are produced, as well 
as a review of good postoperative care and 
the reasons for unsatisfactory results.
The article by Sagel et al. on the newer 
radiologic techniques covers a wide 
variety of procedures now available for 
lesions of the abdomen and chest.
Surgery of the endocrine glands is 
well reviewed—insulomas by Nardi, para­
thyroid glands by Chiu-an Wang, and the 
adrenal glands by Raker. All are excellent.
The biologic principles affecting the 
repair of flexor tendons are discussed in a 
review article by Weiner and Peacock. The 
topic is covered from reaction to injury 
to the operative detail in secondary repair.
The present status of tumour immunol­
ogy is extremely well presented in a brief 
review by Fisher. An excellent bibliogra­
phy is attached.
An account of diverticular disease of 
the colon is given by Zollinger. Pitfalls in 
this disease are well outlined and earlier 
surgical correction is recommended. This 
seems justified because of the high inci­
dence of complications when operation is 
deferred until complications have arisen.
Intra-abdominal sepsis is surveyed by 
Altemeier, Culbertson and Fullen, the 
discussion ranging from primary peri­
tonitis to abscesses involving solid organs. 
The common bacteria encountered are 
noted and the rationale for treatment is 
outlined.
W . J. Buie
Division of Surgery,
University of Calgary,
Calgary, Alta.
ANAESTHESIA IN ORGAN TRANS­
PLANTATION. Edited by T. Hilary 
Howells and Alan W. Grogono. 170 pp. 
Illust. S. Karger, Basel; Intercontinen­
tal Medical Book Corp., New York, 1972. 
$22.50.
To condense a book on anesthesia for 
organ transplantation into 160 pages of 
text seems impossible. For instance, how 
does one deal with the problems associated 
with uremia in three-quarters of a page 
when we know that volumes have been 
written about this subject? Fortunately, 
the saving grace of this book is the well- 
selected references and these would be of 
great help both to the anesthetist speci­
alizing in this type of work and to the 
resident in training who needs as many 
references as possible in his pocket.
The book attempts to cover all the prob­
lems associated with transplantation of 
major organs. A chapter is given to the 
clinical evaluation of death, and at the end 
of the book there is a section on the im- 
munogenetics of graft rejection. These 
two chapters take 50 pages of the original 
text. Except for the fact that it is in­
teresting reading they are of no true value 
to the anesthetist. One wonders if in the 
next edition the authors could use this 
space to expand on the more important 
aspects of organ transplantation.
J. Desmond
Department of Anesthesia,
Toronto General Hospital,
Toronto, Ont.
CARE OF THE CRITICALLY ILL CHILD. 
R. S. Jones and J. B. Owen-Thomas. 323 
pp. Illust. Edward Arnold (Publishers) 
Ltd., London; The Macmillan Company 
of Canada Limited, Toronto, 1971. 
$21.75.
This book attempts to deal with the man­
agement of infants and children critically 
ill from any cause. It appropriately begins 
with a chapter summarizing the general 
philosophy of pediatric intensive care.
Physiologic and biochemical mech­
anisms of disease are presented in an ex­
tensive chapter which includes sections 
on circulatory and respiratory physi­
ology, the latter so detailed and theoreti­
cal as to be understood only by an­
esthetists and those specialist pediatrici­
ans who treat cases in neonatal intensive 
care units. In spite of this criticism this 
and the subsequent excellent chapters on 
the care of sick neonates, and that on 
postoperative cardiac care, make the book 
a valuable asset for the libraries of all 
(Continued on Adv. p. 33)
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pediatric and neonatal intensive care 
units. A later chapter, written by an ex­
perienced intensive care nurse, covers 
nursing techniques comprehensively and 
well but omits the emotional aspects of 
intensive care nursing, now recognized as 
an interesting and important facet in the 
treatment of the critically ill child.
The remainder of the book consists of 
chapters on serious conditions involving 
the other body systems and, in contrast, 
deals with them in a rapid and somewhat 
cursory fashion. Some of the treatments 
recommended are not generally accepted 
in North America (e.g. endotracheal in­
tubation as treatment for acute epiglot­
titis) or are, at best, controversial (e.g. 
intrapleural injections of antibiotics for 
staphylococcal empyema). The reader gets 
the impression that the authors are 
specialists in the handling o f cardio­
respiratory problems, especially in the 
newborn infant, and lack experience in 
other pediatric diseases which can also 
make a child critically ill. One notable 
omission is a section devoted to the man­
agement of the child critically ill from 
multiple injuries.
A final chapter deals with some special­
ized techniques of treatment such as mech­
anical ventilation in infancy, broncho­
scopy and tracheostomy, and with electrical 
monitoring and is chiefly relevant to in­
tensive care units.
Much useful information is available in 
the appendix— nomenclature, formulas, 
normal blood chemistry values, intravenous 
therapy, antibiotics and other drugs. This 
section is conveniently arranged and the 
information is readily available.
This book is well written and a real 
contribution to those treating the critically 
ill child in specialized hospitals and in­
tensive care units. It does not cover in a 
consistent and organized way what its title 
implies and therefore will be of little 
value to the general pediatrician, phy­
sician or surgeon who finds himself treat­
ing the critically ill child in emergency 
departments and smaller hospitals across 
the country.
J. C. Fallis
I.O.D.E. Children’s Medical Centre,
North York General Hospital,
Willowdale, Ont.
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EMBRYOLOGY FOR SURGEONS. The 
Embryological Basis for the Treatment 
of Congenital Defects. Stephen Wood 
Gray and John Elias Skandalakis. 918 
pp. Illust. W . B. Saunders Company, 
Philadelphia; W . B. Saunders Company 
Canada Limited, Toronto, 1972. $37.10. 
The title of this book clearly emphasizes 
its purpose—to make available to surgeons 
a well-organized description of normal 
fetal evolution and of errors in develop­
ment which become manifest in infancy, 
childhood and adult life.
Each chapter deals with an organ or 
portion of an anatomical system. This sys­
tematic approach makes for clarity, and at 
the same time the authors have freely 
included pertinent details of regional 
significance. Sections describing the stages 
in development are concise and explicit. 
The text is liberally illustrated by good 
line drawings, photographs of wax models, 
radiographs and clinical photographs. The 
process of gradual deviation from the nor­
mal development is clearly described for 
each anomaly. In each chapter an excellent 
table lists the salient features of each 
anomaly in a series of malformations.
Clinical features, differential diagnoses 
and classifications are brief but pertinent. 
Discussion of surgical treatment is limited
to a statement of principles involved and 
corrective procedures generally used. 
Technical descriptions of operations are 
excluded except as they relate to ana­
tomical and embryologic considerations.
The bibliography at the end o f each 
chapter is extensive and correlates well 
with the liberal and skilful use o f re­
ferences throughout the text. Brief his­
torical sections are complementary and 
serve to remind us that embryology is a 
science of painstaking observation and 
deduction.
Surgeons may disagree with certain 
points of emphasis in areas of their own 
special interest. For instance, the obvious 
anatomical and radiologic manifestations 
of hiatus hernia here overshadow considera­
tion of the symptoms and control of gastro­
esophageal reflux. Also, the clinically in­
significant islands of heterotopic gastric 
mucosa in the upper esophagus take undue 
precedence over a lower esophagus lined 
with gastric mucosa— a condition worthy 
of special anatomical and surgical con­
sideration.
The volume omits any account of the 
embryology and anomalies of the inte­
gument, the musculature, face, teeth, 
skeletal and nervous systems.
(Continued on A dv. p. 37)
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All communications concerning this journal 
should be marked “’The Canadian Journal of 
Surgery” and addressed to the Editor, P.O. 
Box 8650, Ottawa, Ontario K1G 0G8.
The Journal is published bi-monthly. Sub­
scription is $15 per year ($7.50 per year for 
trainees in surgery) and starts with the Janu­
ary issue of each year. Single copies are $2.50 
each, payable in advance.
INSTRUCTIONS TO CONTRIBUTORS 
Manuscripts
Manuscripts in duplicate of original articles, 
case reports, and other contributions should 
be forwarded with a covering letter re- 
auesting consideration for publication in 
The Canadian Journal o f Surgery. Accept­
ance is subject to the understanding that 
thev are submitted solely to this Journal, 
and will not be reprinted without the con­
sent of the author and the publishers. Ac­
ceptance or rejection of contributions will 
be determined by the Editorial Board. As 
space is available, a limited number of case 
reports will be published. Articles should 
be typed on one side only of unruled paper, 
double-spaced, and with wide margins. The 
author should always retain a carbon copy 
of material submitted. Every article should 
contain a summary of the contents. The 
Concise Oxford Dictionary will be followed 
for spelling. Dorland’s Illustrated Medical 
Dictionary will be followed for scientific 
terminology. The Editorial Board reserves 
the right to make the usual editorial changes 
in manuscripts, including such changes as 
are necessary to ensure correctness of gram­
mar and spelling, clarification of obscurities 
or conformity with the style of T he Cana­
dian Journal o f Surgery. In no case will 
major changes be made without prior con­
sultation with the author. Authors will 
receive galley proofs of articles before pub­
lication and are asked to confine altera­
tions of such proofs to a minimum.
Reprints
Beprints may be ordered on a form which 
will be supplied with galley proofs. It is 
important to order these before publication 
of the article, otherwise an extra charge 
for additional type-setting will be made.
References
References should be referred to by numer­
als in the text. They should include in 
order: the author’s name and initials in capi­
tals, title of the article, abbreviated journal 
name, volume number, page number and 
year. The abbreviations of journal names 
should be those used in Index Medicus. 
References to books should include in order: 
author’s name and initials, title of book, 
number of edition (e.g. second ed.), city 
of publication, title of publishing house, 
year of publication, page number if a 
specific reference. For examples, see this 
journal January 1971 issue onwards.
Illustrations
A reasonable number of black-and-white 
illustrations will be reproduced free with 
the articles. Colour work can be published 
only at the author’s expense. Photographs 
should be glossy prints, unmounted and 
untrimmed, preferably not larger than 8" 
x 6". Prints of radiographs are required 
and not the originals. The magnification of 
photomicrographs must always be given. 
Photographs must not be written on or 
typed on. An identifying legend may be 
attached to the back. Patients must not be 
recognizable in illustrations unless the 
written consent of the subject for publica­
tion has been obtained. Graphs and dia­
grams should be drawn in India ink on 
suitable white paper. Lettering should be 
sufficiently large that after reduction to 
fit the size of the Journal page it can still 
be read. Legends to all illustrations should 
be typed separately from the text and sub­
mitted on a separate sheet of paper. Illustra­
tions should not be rolled or folded.
Language
It should be clearly understood that con­
tributors are at full liberty to submit articles 
in either English or French, as they please. 
Acceptance will be quite independent of 
the language of submission. If the contri­
butor wishes, he may submit an informative 
summary of not more than 300 words in 
the language other than that in which he has 
submitted the article. For example, an ar­
ticle in English must carry an English sum­
mary and may, if the author wishes, carry 
a more detailed summary in French.
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The two authors have combined their 
very considerable talents for informative, 
concise and lucid writing to produce a 
text of practical value to both anatomist 
and surgeon.
T. K. T horlakson
Winnipeg Clinic,
Winnipeg, Man.
MANUAL OF SURGICAL THERAPEU­
TICS. 2nd ed. Edited by Robert E. Con­
don and Lloyd M. Nyhus. 385 pp. Illust. 
Little, Brown and Company, Boston; J. 
B. Lippincott Company of Canada Ltd., 
Toronto, 1972. $7.95. Paperbound.
Although this manual is titled “ Surgical 
Therapeutics” it also encompasses diag­
nosis. Details of operative treatment are 
not included.
In outline form, but with adequate 
discussion, an abundance of useful in­
formation is presented so that the surgical 
house officer and student can readily refer 
to this source in the daily management of 
the problems he will unquestionably en­
counter. Pathophysiology is included when 
indicated to clarify concepts and pro­
cedures.
The chapters cover the evaluation and 
management of trauma, shock, cardiac 
arrhythmias and arrest, surgical infec­
tions, preoperative and postoperative care 
with an excellent discussion of nasogastric, 
long intestinal, Sengstaken-Blakemore, com­
mon duct and chest tubes (about which 
junior surgical house officers frequently 
display considerable concern), fluid and 
electrolyte therapy, postoperative compli­
cations, respiratory and renal insufficien­
cy, a complete discussion of burns, dif­
ferential diagnosis of abdominal pain, 
massive gastrointestinal hemorrhage, in­
testinal obstruction, venous disorders of 
the lower extremities, common anorectal 
disorders and a final short chapter on 
pediatric surgery. Notably absent is a 
section on cardiovascular and open heart 
surgical problems.
This manual is highly recommended for 
fourth-year medical students and house of­
ficers. In addition it provides an up-to- 
date, concise, but all-inclusive review of 
value to all surgeons regardless of special­
ty.
J. B. L i t t l e f i e l d
Department of Surgery,
Memorial University of Newfoundland,
St. John’s, Nfld.
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TEXTBOOK OF ELECTROCARDIOGRA­
PHY. David Littmann. 553 pp. Illust.
Harper & Row, Publishers, Inc., New
York, 1972. $22.50.
This is an excellent book which fu lfils a 
defin ite  need fo r a textbook of electrocar­
diography shorter and less detailed than 
the more extensive volumes on the  subject, 
bu t more adequate than  the beginner’s 
m anuals. The book is easy to read and, un­
like m ost textbooks on technical m atters, is 
made in terestin g  to read by the au th o r’s 
lavish use of illustrative trac ings of high 
quality.
The f ir s t  chapter on electrophysiology 
and the normal ECG is ra th e r  superficial 
and will not satisfy  the more inquiring  
senior student or house officer bu t will be 
adequate fo r anyone w anting a thum b-nail 
sketch of the subject. A slightly more com­
plete review, w ith more em phasis on the 
recent advances in in tracard iac electro­
gram s and His bundle studies, would make 
the discussion in the succeeding chapters 
of clinical abnorm alities related to a rrh y th ­
m ias, junctional rhythm s, and various 
form s of h ea rt block more in te resting  for 
the non-cardiologist reader who is not 
fam iliar w ith the recent lite ra tu re  in th is 
area. The final chapter dealing w ith the 
method of approach to the unknown ECG is 
especially relevant in allowing the reader to 
put into proper perspective w hat he has 
learned from  the book.
The bib liography  is adequate  bu t tends 
to cover the classical papers on the  various 
disorders a t the expense of the m ost recent 
reviews. This, however, is a m inor fau lt in 
a book of th is nature.
In essence, Dr. L ittm ann’s book is to  be 
highly recommended fo r senior medical 
students and all levels of house officer. I t 
will be m ost useful to the non-cardiologist 
clinician who requires a comprehensive but 
easily readable textbook on electrocardio­
graphy. The high quality of the illustrative 
tracings and the clear descriptions below 
them add to the clarity  of the text.
Paul H. Tanser
D epartm ent of Cardiology,
Royal Victoria Hospital,
Montreal, Que.
TRANSPLANTATION GENETICS OF 
PRIMATES. Edited by Hans Balner and 
Jon J. van Rood. 152 pp. Illust. Grune 
& Stratton, Inc., New York; Longman 
Canada Limited, Toronto, 1972. $14.70.
This m onograph contains the published 
proceedings of the F ir s t  In ternational
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Histocompatibility Workshop and Sympo­
sium on Primates held in September 1971 
in Rijswijk, The Netherlands. The text as­
sembles a large volume of interesting data 
and the overall clarity is enhanced by the 
joint report of the Workshop. This report, 
forming the last chapter in the book, con­
tains the analyses of the Workshop data and 
the conclusions reached during the discus­
sion of results. A total of 202 primates were 
typed: 60 chimpanzees and 142 rhesus 
monkeys (87 unrelated, and 55 children of 
the families). The typing results were an­
alyzed by sophisticated computer programs. 
RhL-A system was recognized as the major 
histocompatibility system of rhesus mon­
keys. Following the procedure used at the 
Fourth International Histocompatibility 
Workshop on Humans in 1970 the antigenic 
groups were divided into RhL-A and RhW 
(Workshop) designations, to which were as­
signed three and eight specificities respect­
ively. For chimpanzees, only ChW designa­
tions were assigned, since no family data 
were available. The groups of antisera de­
fining chimpanzee specificities shown to be 
the unequivocal analogues of human anti­
gens were given HL-A-related designations, 
e.g. ChW4 for 4a, ChW6 for 4b, and ChW ll 
for HL-A11. ChW groups not related to 
known HL-A specificities were assigned 
sequence numbers above 100.
The main text of the book comprises pa­
pers presented by various investigators at 
the symposium. It is confusing, at least in 
the beginning, since each investigator uses 
his own nomenclature. However, the data 
presented are interesting and stimulating. 
The experience gained in the field of human 
leukocyte antigens afforded a tremendous 
advantage in studying serology, genetics 
and chemistry of antigens of primates. The 
similarity between the role of RhL-A for 
histocompatibility in monkeys and the role 
of HL-A in human transplantations is evi­
dent from the data presented by Balner et 
al. Using human leukoagglutinating sera to 
study leukocyte groups of baboons, Down­
ing et al. observed that baboons have a 
leukocyte antigen that resembles HL-A7 in 
humans. A number of papers discuss the 
similarities, differences and cross-reactions 
between HL-A and ChL-A. This will be an 
indispensable reference book for any person 
interested in leukocyte antigens of pri­
mates.
D. P. SlNGAL
Department of Pathology,
McMaster University Medical Center, 
Hamilton, Ont.
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